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ABSTRACT 
 
Investigations of the chemical content of the brain and its many constitutive cell types yield 
information regarding normal and abnormal brain function.  Frequently, proteomics, 
peptidomics, and metabolomics experiments survey brain regions and attribute detected 
species to neurons.  However, many other cell types are present, including astrocytes, 
oligodendrocytes, and microglia.  It is also known that different cell types can vary greatly in 
their analyte content and concentration; therefore, to obtain an adequate representation of 
brain function, specific cell types require further characterization.  Cell types of particular 
interest are astrocytes, which are involved in neuronal communication, and mast cells, which 
are involved in allergic response.  Moreover, morphologically similar cells can exhibit 
chemical heterogeneity; to characterize these differences, single-cell analyses are necessary.  
In this case, single cells from the model organism, Aplysia californica, are isolated for 
analysis.  Mass spectrometry (MS) is well-suited for such applications because it has limits 
of detection in the attomole range for both small molecule metabolites and peptides, has a 
wide dynamic concentration range, and can detect and identify molecules of interest without 
a priori knowledge of sample content.   
 To characterize metabolite profiles in single cells and tissue homogenates, a 
laboratory-built capillary electrophoresis (CE) system coupled to electrospray ionization 
(ESI) MS is implemented.  This is a useful technique for such measurements because it only 
requires a small amount of sample (injection of nanoliter volumes), it can efficiently separate 
and detect hundreds of analytes within a single CE separation, and it has detection limits in 
the low nanomolar (attomole) range for several neurotransmitters.  This technique has been 
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successfully applied to characterize and chemically distinguish single cells of various neuron 
types from Aplysia californica.  Here, hundreds of ions are detected within single-cell 
samples and 36 ions are identified.  Furthermore, neuron-specific analytes are revealed, 
chemical classification of neurons is achieved via principal component analysis, and cellular 
concentrations of serine and glutamic acid are determined for the different neuron types.  CE-
ESI-MS has also been effective in determining relative chemical differences between 
different sample types.  To determine the chemical contribution that mast cells make to the 
brain, tissue homogenates from mast cell-deficient mice are compared to their heterozygous 
littermates.  In this comparison, a number of metabolites, including amino acids and choline, 
are statistically different between the two sample types; furthermore, this data agrees with 
differences observed in gene expression data.  The combined metabolite and transcriptomics 
data reveal global chemical differences that affect a number of metabolic pathways, which 
may be related to behavioral and developmental traits observed in mast cell-deficient mice.  
The characterization of peptide content in astrocytes is also achieved by employing several 
instrumental platforms, such as CE-ESI-MS and matrix-assisted laser desorption/ionization 
MS.  By carefully selecting defined samples, the identification of a large number of peptides 
from purified astrocyte samples is accomplished. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Research Motivation 
Characterizing how the brain functions is a challenging and ongoing task.  While different 
brain regions are associated with certain tasks, such as the hippocampus with learning and 
memory, the specific mechanisms underlying complex behaviors and responses, such as how 
memory is retained, remain somewhat elusive.  There is also a large diversity of cell types 
present in the central nervous system (CNS), such as neurons, astrocytes, microglia, and mast 
cells.  Even cells of the same type exhibit chemical heterogeneity.1-5   However, many bulk 
chemical analyses of tissue homogenates from the brain attribute major findings to be 
neuron-specific, despite this cellular diversity.  To determine the chemical influences that 
non-neuronal cell types contribute to the brain, defined samples are obtained either via 
isolation, cell culture, or using genetic knockouts.  Also, single neurons are also isolated to 
gain specific chemical information that is lost in homogenate studies.  Metabolites to 
peptides are investigated from these specialized samples to better characterize the chemistry 
of these biological systems. 
 Mass spectrometry (MS) is an incredibly useful analytical technique that has been 
applied to a variety of biological sample matrices.  A particularly attractive feature is that a 
priori knowledge of chemical content is not necessary to detect and identify molecular 
species that are present.   Furthermore, the limits of detection, sensitivity, and dynamic 
concentration range are sufficient for single-cell analyses.  Both electrospray ionization (ESI) 
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and matrix-assisted laser desorption/ionization (MALDI) are heavily utilized in bioanalytical 
applications due to their ability to analyze a large variety of analytes of interest, such as 
metabolites, peptides, and proteins.6-9  Due to the chemical complexity that is often 
associated with biological sample extracts, a separation step prior to ionization can provide 
additional confirmation regarding analyte identity and reduce interfering species.  Capillary 
electrophoresis (CE) is implemented due to its compatibility with small sample volumes and 
ability to separate analytes by size and charge rather than relying on polarity differences.10-12  
Liquid chromatography is also coupled to MS for the separation, detection, and identification 
of peptides in cellular sample matrices.  The combination of these analytical techniques 
enables measurements from multiple biological samples of interest, which yields a better 
understanding of the chemistry of these specific cell types. 
 
1.2 Thesis and Research Overview 
The remaining sections of Chapter 1 will discuss the different cell types and model 
systems/organisms investigated in the current work and why they were chosen.  Chapter 2 
presents an overview of different ionization approaches that are hyphenated to mass 
spectrometry for the detection of diverse chemical species from single cells.  Chapter 3 is a 
protocol chapter which gives explicit instructions for isolating single cells from Aplysia 
californica and characterizing them for metabolite content using MALDI MS and ESI MS.  
Chapter 4 describes the metabolic profiles of single cells isolated from Aplysia californica.  
Cell types are chemically distinguished via principle component analysis (PCA), cellular 
heterogeneity within the same neuron type is characterized, unique molecular features 
corresponding to individual neurons are discovered, and quantitation of two amino acids 
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within single neurons is achieved.  Chapter 5 discusses the differences in chemical content of 
mouse hippocampi that contain or lack mast cells with the use of a genetic knockout.  Global 
molecular changes are determined by combining metabolite and transcriptomic data.  In 
particular, choline and multiple amino acids differ, which may influence behavior, learning, 
and neurogenesis.  Chapter 6 provides information regarding peptide characterization in a 
pure population of astrocytes that is achieved through single-cell analyses, cell culture, and a 
transgenic mouse with fluorescently identifiable cells; this research yields further insight into 
the complexities of chemical communication of astrocytes.  Chapter 7 is an expansion upon 
experiments described in Chapter 4 where metabolic content is characterized for neuronal 
cultures, cell clusters, and isolated neurons via CE-ESI-MS; metabolite profiling using three 
different approaches results in a better understanding of investigated Aplysia neurons and 
neuron clusters and how they respond to different environments.  
 
1.3 Cell Types and Model Systems  
1.3.1 Aplysia californica 
The model organism, Aplysia californica, provides an excellent opportunity for investigating 
individual neurons that assemble into networks that are responsible for complex actions and 
behaviors.  It was the characterization of this model that led to Eric Kandel receiving the 
Nobel Prize for Physiology or Medicine in 2000.  For example, distinct, identifiable neurons 
are responsible for inducing the gill-withdrawal reflex, where studies of learning and 
memory are performed.13  Furthermore, the neurons are some of the largest in the animal 
kingdom, with some neurons up to 1 mm in diameter.14  Aplysia have approximately 10,000 
neurons in their CNS,15 while the mammalian brain has on the order of 1011 neurons.16  The 
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mapping of the Aplysia genome is also underway, which will enable comparisons of this 
model organism to more complex systems, such as mice, rats, and humans.  Aplysia neurons 
are also relatively easy to isolate and the location of respective identifiable neurons has been 
characterized and mapped.17  With this defined system, a variety of experiments can be 
performed on a single-cell level.  In this work, the metabolite content of individual, identified 
neurons is characterized to better understand how the chemical milieu relates to function.   
 
1.3.1.1 Aplysia Neurons 
The Aplysia neurons of interest are listed in Table 1.1.  While these neurons have been 
researched extensively, CE-ESI-MS has the capability to measure over one hundred analytes 
from a single cell.11  Thus, experiments were performed to determine if neurons could be 
distinguished chemically based on their biochemical profile.  Neurons that were chosen to be 
investigated are diverse in function and location, while others have similar properties.  For 
example, while the R2 and LPl1 are located in different ganglia, they are similar both in their 
electrophysiological properties and levels of acetylcholinesterase.18-19  Similarly, the B1 and 
B2 neurons have been shown to be similar, but their chemical characterization has been 
mostly for neuropeptide content.20-21  However, the full metabolic similarities of these 
neurons are unknown.  While the R3-13 cluster is in close proximity to the R15 neuron in the 
abdominal ganglion, they are involved in very different functional activities, which are 
influenced by neuropeptides.22-27  In contrast, the metacerebral cell (MCC) is involved in 
feeding28 and is known to be serotoninergic29.  However, these neurons may have additional 
small molecule transmitters and in some cases the neurotransmitter is unknown.  By using 
principal component analysis (PCA), the extent of these cellular similarities and differences 
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with respect to chemical content are visualized.  Unique chemical features that are neuron-
specific are also obtained.   
Another specific neuron of interest is the L7 motor neuron; it is involved in the gill-
withdrawal reflex, which is a model for investigating learning and memory, but the chemical 
mediator for this action is unknown.16, 30-32  Furthermore, this neuron is difficult to 
unambiguously identify without lengthy electrophysiological testing; however, identification 
of the L7 neuron can be visually limited to two candidate neurons based on location and size.  
By chemically characterizing multiple biological replicates of these two candidate L7 
neurons, it appears that these two neurons can be chemically distinguished.  CE-ESI-MS is 
also used to examine changes in metabolite profiles that result from culturing.  This is 
necessary because cell culture is common in bioanalyses and is an attractive option compared 
to in vivo work due to it being a less complicated system to study under defined conditions; 
furthermore, the results of culturing studies are often extended to the in vivo system.  
Culturing can be a somewhat harsh process, due to potentially necessary components being 
absent.  This analytical technique enables single cell responses to culturing to be 
investigated.  It is determined that the extent of neuronal response under these conditions is 
dependent upon cell type.   
 
1.3.2 Mus musculus and Rattus norvegicus 
Mice and rats are typically used as model organisms to characterize biological and chemical 
properties of mammalian systems, which can be a precursor or substitute for research of 
human subjects.  Both share physiological and anatomical similarities, which make them 
ideal for biomedical investigations as well as other research avenues regarding the 
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fundamental understanding of underlying biochemical processes.  Furthermore, with the 
characterization of the human, mouse, and rat genomes, direct comparisons can be made on a 
molecular level between these organisms.  Mice are relatively easy to genetically modify, 
which enables a number of functional studies to be accomplished, which are typically based 
on a knock-out of a definable trait to determine what effect it locally and globally inflicts on 
the animal.  Rats are relatively larger animals with larger anatomical features than mice, 
resulting in easier working volumes for tissue sampling.  Both mice and rats offer 
complementary advantages; therefore, both are utilized to study the following cell types in 
the mammalian brain.        
 
1.3.2.1 Mast Cells 
Mast cells are well known for their involvement in allergic response.  Upon binding of an 
antigen to surface-bound immunoglobulin E, these cells generate and release chemical 
mediators, including histamine.33  These meditators are localized in large vesicles that can be 
quickly released upon activation.  These cells have also been implicated in immune 
response;34-36 mast cells release cytokines, such as tumor necrosis factor and interleukin-4, in 
response to pathogens.35  These cells are also heterogeneous;37 mast cells tend to be 
characterized under two categories: mucosal and connective tissue mast cell types.  They can 
even change phenotype if isolated and placed from one environment to another.38-39  
However, characterization of mast cells in the brain requires further study.   
Mast cells have been confirmed to be present in the brain relatively recently.40  The 
presence of mast cells in the brain was surprising because the brain was considered an 
immune-privileged site that excludes circulating cells.41  Mast cells have to cross the blood-
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brain barrier to gain access to the brain.42    Their location in the brain is limited to distinct 
regions, which is also species dependent.43  The number of mast cells present has been 
demonstrated to be a dynamic process, where certain stimuli will induce mast cell numbers to 
change in the brain.41-42, 44-47  The function of mast cells within the brain has started to be 
investigated. 
 As mentioned previously, mice are often genetically modified to determine functional 
properties of a particular characteristic.  Likewise, a mutant is available that lacks mast cells, 
allowing mast cell effects to be investigated in vivo.48-49  For example, mast cell-deficient 
mice were compared against controls to determine if any behavioral differences existed, and 
therefore define mast cell-dependent behavior;50 it was shown that mast cell-deficient mice 
exhibit anxiety.  In the current work, mast cell-deficient mice are compared to controls to 
ascertain global chemical differences in the hippocampus, which can then be related to this 
observed behavioral difference.  
 
1.3.2.2 Astrocytes  
Glia outnumber neurons in the mammalian brain and the size of the glia population is 
dependent upon the area of the brain and the organism.  Glia are a heterogeneous cell 
population, which includes astrocytes, oligodendrocytes, and Schwann cells, among others.  
Even within the individual glia subtypes, there is heterogeneity.5  Schwann cells are 
responsible for the myelination of the peripheral nervous system, while oligodendrocytes 
myelinate axons in the central nervous system.  Astrocytes, however, seem to have diverse 
functional capabilities.   
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Astrocytes are well positioned to chemically communicate with neurons; their 
processes are intricately connected to pre- and post-synaptic neuronal connections.  Chemical 
signaling was demonstrated after the observation that increases in intracellular Ca2+ 
concentration in cultured astrocytes induced glutamate release followed by neuronal 
activation.51  “Gliotransmitters” have been shown to be released by astrocytes and include 
glutamate, adenosine triphosphate, adenosine, and D-serine.52  To be characterized as a 
gliotransmitter, it has been proposed that it should fulfill the following parameters: (i) 
synthesis by and/or storage in glia, (ii) regulated release triggered by physiological stimuli, 
(iii) activation of rapid (milliseconds to seconds) responses in neighboring cells, and (iv) a 
role in physiological processes.52  
While the mechanisms of the release of these small molecule transmitters are still 
being researched, peptide signaling in astrocytes also requires further investigation.  There is 
mRNA expression data that indicates that peptides could be produced, such as 
angiotensinogen and proenkephalin.53-54  The process for the synthesis of neuropeptides is as 
follows: (i) translation of mRNA to generate the preprohormone precursor, (ii) proteolytic 
removal of the NH2-terminal signal peptide at the rough endoplasmic reticulum, (iii) the 
prohormone is packaged into vesicles with processing proteases in the Golgi apparatus, and 
(iv) proteolytic processing of the peptides are achieved by the proteases in the vesicle, 
typically at dibasic or monobasic sites.55  Neuropeptides may also undergo posttranslational 
modifications, which can modify the biological activity of the peptide.  MS has proven to be 
an indispensible tool in identifying neuropeptides in tissue homogenates and single cells and 
also yields information about they are processed.  In this work, MS is implemented to 
characterize peptide content from pure populations of astrocytes by using a cell line, primary 
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cultures, and isolated cells directly from the brain using a transgenic mouse model and 
fluorescence-activated cell sorting.  The identification of a large number of peptides from 
astrocytes was achieved; however, no classical neuropeptides were detected, which could be 
a result of a lack of context-specific input or lack of processing enzymes. 
 
1.4 Conclusions 
A variety of cell types are analyzed for chemical content, from small molecules to peptides, 
using MS.  Single-cell analyses of Aplysia neurons enable investigations of cell-to-cell 
heterogeneity, metabolically distinguishing characteristics of different cell types, and effects 
induced by cell culture.  These analyses complement transcriptomic, proteomic, and 
peptidomic investigations, which results in a more complete understanding of the chemical 
content of these individual neurons and how this relates to function.  Characterization of non-
neuronal cell types in the brain is also necessary to fully understand how the brain works.  It 
is determined that mast cells alter a surprising range of metabolites and gene expression in 
the hippocampus, which are implicated in a number of critical pathways.  Astrocytes are 
studied using several approaches, which include cell culturing techniques and genetically-
modified mice to better understand how astrocytes communicate chemically.  The combined 
information gained from these investigations stress the importance of non-neuronal and 
single-cell investigations with regard to function. 
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1.5 Tables 
Table 1.1 Aplysia neurons that are isolated and investigated for metabolic composition. 
While one transmitter is listed, others are/may be present.  The location refers to the ganglion 
in which this cell is located.  Key: Left pleural 1 (LPl1), Metacerebral cell (MCC) 
 
Neuron Location Transmitter Action/Involved in
B1 Buccal neuropeptides Gut motility
B2 Buccal neuropeptides Gut motility
LPl1 Pleural acetylcholine Regulation of mucus release, Control of the feeding process
MCC Cerebral serotonin Control of the feeding process
L7 Abdominal unknown Gill-withdrawl reflex
R2 Abdominal acetylcholine Regulation of mucus release
R3-13 Abdominal neuropeptides Cardiac function
R15 Abdominal neuropeptides Egg laying, Regulation of water balance
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CHAPTER 2 
 
SINGLE-CELL MASS SPECTROMETRY 
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2.1 Introduction 
Mass spectrometry (MS) has been widely used to investigate a variety of biological systems, 
ranging from subcellular structures to entire organisms.  This powerful analytical technique 
has enabled the characterization and identification of a plethora of analytes including 
elements, metabolites, peptides, and proteins.  Furthermore, spatial, temporal, and chemical 
information can be obtained from bioanalytical MS measurements.  One promising 
application of this information-rich approach has been in single-cell investigations—cellular 
measurements that have advanced the understanding of tissues and organisms at a 
fundamental level.  These experiments have yielded detailed insights regarding many 
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biological functions.  Although there are multiple techniques capable of detecting analytes of 
interest within a cell, what sets MS apart is its ability to simultaneously detect and identify 
many analytes without preselection or tagging.  Post-translational modifications and 
prohormone processing can also be determined.  Moreover, cell to cell differences in 
chemical heterogeneity can be characterized via MS.  
Different cell types often vary greatly in their analyte amounts and concentrations, 
and even morphologically similar cells show differences in analyte profiles.  Accordingly, 
single-cell studies demand methods that meet three key requirements: high sensitivity, 
chemically-rich information, and a wide dynamic range.  Because MS is a highly sensitive 
technique, with detection limits for many MS-based approaches in the attomole range, it is 
well-suited for probing single-cell biochemistry.  In fact, efforts to improve detectors in MS 
instrumentation have resulted in detection efficiencies approaching 100%.2  Finally, the wide 
dynamic range of MS facilitates the characterization of analytes over large variations in their 
concentration. 
Single-cell MS has been used to examine many cell types from a variety of 
organisms, ranging from unicellular organisms such as bacteria and yeast, to complex 
animals such as mammals.  The invertebrates Aplysia californica and Lymnaea stagnalis 
have been popular model systems for the development of single-cell MS because of their 
well-defined neuronal systems in which cells are relatively easy to identify, isolate, and 
physiologically test.3-8  These single-cell MS studies have resulted in the discovery of many 
cell-to-cell signaling molecules, including information on their location, release and function.  
Smaller cells from a variety of insect models—the moth,9 fruit fly,10-11 and cockroach12—
have also been successfully investigated with single-cell MS.  The success of these 
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invertebrate studies has led to the application of this technology to more structurally complex 
mammalian tissues, with most cells being no larger than 10–20 µm in size.  It follows that 
increasing the sensitivity of MS detection, as well as improving sample quality and 
preparation, must be emphasized in continued efforts to advance and optimize this 
methodology. 
Given the small sample volumes and relatively low levels of analyte inherent to 
single-cell experiments, it is not surprising that their success depends heavily on sample 
quality.  Exceptional attention must be given to cell isolation, handling, and analyte 
extraction.  Choosing the right sample preparation technique, which is highly dependent upon 
the analytical method being used and the analyte of interest, is also important. Here, three 
major ionization approaches used in single-cell MS studies are discussed: matrix-assisted 
laser/desorption ionization (MALDI) MS, secondary ion mass spectrometry (SIMS), and 
electrospray ionization (ESI), as well as the appropriate sample preparation process for each.  
 
2.2 Mass Spectrometry  
In MS, analytes are ionized in some fashion and then introduced into the mass analyzer, 
where the ions are focused and separated based on analyte properties, such as kinetic energy 
or momentum.  From this, the mass-to-charge ratio (m/z) of the ion is calculated.  One can 
determine the charge and experimental mass of the detected species by considering the 
isotopic distribution and position of the ions in the resulting mass spectrum.  Modern mass 
spectrometers can characterize analytes with high mass accuracy, often in the low parts per 
million range.  Maintaining high mass accuracy aids in analyte identification, in part by 
matching the measured and theoretical masses for specific analytes; however, one often 
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cannot unequivocally identify an analyte based on its detected mass alone. Additional 
techniques can serve to confirm MS identifications; for example, using standards, 
implementing in situ and immunohistochemical approaches, and/or incorporating additional 
MS data.  In an approach known as tandem MS (MS/MS), the molecular ion of the analyte of 
interest can be fragmented and the identity determined by the resulting fragmentation pattern.  
If the concentration of the analyte is not high enough for tandem-assisted studies, which is 
often the case for single-cell analyses, samples can be pooled to increase the amount of 
analyte available for investigation. 
The most common ionization methods used for complex biological samples are 
highlighted here.  Note that a single ionization method is not always sufficient; rather, they 
can provide complementary information.  A more in-depth coverage of other aspects of mass 
spectrometers, such as mass analyzers and detectors, can be found elsewhere.13-14 
 
2.2.1 Matrix-Assisted Laser Desorption/Ionization 
A great advantage of using MALDI MS is that it allows the direct analysis of individual cells 
and can ionize a wide range of analyte classes, including lipids and proteins.  As mentioned 
previously, this technique has a high sensitivity with a dynamic range amenable to single-cell 
analysis.  In MALDI, analytes are incorporated into a matrix, such as α-cyano-4-
hydroxycinnamic acid (CHCA) or 2,5-dihydroxybenzoic acid (DHB).  These specific 
matrixes are commonly used to analyze peptides and proteins, but there are many other 
MALDI matrixes available, often ideal for specific analyte classes.  During sample 
preparation, the matrix is dissolved in solvent and applied to the sample—the solvent 
evaporates and the analytes are incorporated into the matrix as it crystallizes.  To ionize 
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analytes, a laser, with a wavelength strongly absorbed by the matrix, irradiates the sample 
spot (Figure 2.1A).  This causes rapid vaporization and ionization of the matrix molecules; 
the analyte is also vaporized and ionized during this process.  MALDI is considered a "soft" 
ionization technique because intact molecules are ionized with little to no fragmented species 
observed.  For a more detailed explanation of the ionization process, there are several 
reviews that thoroughly describe the specific mechanisms involved.15-18 
A number of factors must be considered when planning a MALDI MS experiment.  
For example, the MALDI matrix should be selected according to the class of analyte being 
examined.  The matrix should also be soluble in the solvent chosen and used at 
concentrations known to lead to efficient MS detection.  The solvent plays an important role 
in the sample preparation process; slower solvent evaporation results in more time for analyte 
extraction and incorporation into the MALDI matrix.  Some substances may hinder MALDI 
matrix crystal formation, including organic buffers and inorganic salts.  However, in 
comparison with other ionization methods, MALDI is fairly tolerant to these factors.  Using a 
higher matrix concentration can aid in appropriate crystal formation in the presence of 
physiological salts.19  The matrix concentration and volume applied to a sample should also 
be optimized for that sample.  In addition, mixed matrixes can aid in obtaining better results 
with MS profiling.20  Recrystallizing the MALDI matrix while on the sample can create 
better crystals and aid in the removal of salt;21 however, with single-cell sampling, if the 
matrix spot is too large, this results in dilution of the analyte, making its characterization 
problematic.  Efforts to promote increased ionization with the addition of ion pairing agents 
to the matrix, or coating the sample with gold,22 have been reported.  As mentioned, due to 
the small size of most cells and thus, the typically low amounts of available analytes, the 
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quality of cell isolation, handling, and analyte extraction is often essential for experimental 
success.  The sample preparation strategies for single-cell MALDI must be selected with 
regard to the specific organism and cell type under investigation.  
 
2.2.1.1 Sample Preparation for Single-Cell MALDI 
Several strategies have been implemented to obtain chemical information from single-cell 
samples with MALDI MS.  Typically, individual cells are isolated from tissues or organs 
using enzymatic or nonenzymatic approaches and transferred onto the MALDI target where 
matrix is applied onto the cell. Early studies using single-cell MALDI MS were performed 
with neurons from the mollusks Lymnaea stagnalis and Aplysia californica.3-8  Aplysia, a 
marine sea slug, presents an additional challenge because its extracellular environment 
includes >450 mM NaCl.  To address this issue, a procedure of washing Aplysia cells with an 
aqueous solution of DHB was introduced to remove excess salts, while maintaining the 
integrity of the cell membrane.23  The concentration of inorganic salts also can be 
significantly decreased by microextraction procedures; for example, analytes released from 
stimulated Aplysia bag cell neurons were captured by solid-phase extraction beads placed at 
the site of release.24-25  The beads are then washed to reduce the amount of salts in samples 
without significant loss of analyte, resulting in an increase in signal intensity.  In situations 
where extracellular inorganic salts are present in lower amounts, sample conditioning steps 
can be omitted.  For example, smaller insect cells have been isolated without enzyme 
treatment, exposed directly to the matrix, and analyzed with MALDI MS, with an 
outstanding profile of signaling peptides demonstrated.9, 11-12  Additional optimization of 
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sample preparation and signal acquisition protocols is required when smaller cells with lower 
concentrations of analytes need to be investigated using MALDI MS. 
Direct analyses of cells with MALDI MS benefit from the confinement of cellular 
analytes to a small surface area, especially with smaller cell types.  This is necessary to 
reduce analyte spreading during sample preparation.  One successful approach has used a 
small volume capillary for cell lysis with spatially defined analyte deposition.26  In this case, 
red blood cells were lysed inside a capillary and spotted onto a MALDI target; the detected 
analytes were from hemoglobin, which is obviously highly abundant in red blood cells.  
Laser capture microdissection can also be employed for precise isolations of single 
mammalian cells from tissue sections for protein detection.27  Another isolation protocol for 
single mammalian cell detection involves the addition of a glycerol-containing solution to 
stabilize the cell membranes and prevent cell lysis during isolation, without a detectable 
change in the biochemical profile of the cell.28-30  After cells are incubated in a glycerol 
solution for approximately 15 min, a glass micropipette is used to isolate single cells (Figure 
2.2).  Next, the individual cells are transferred to the surface of a clean, indium-tin-oxide-
coated microscope slide or glass coverslip.  One must be careful at this point to make sure 
that the isolated cell does not include any excess glycerol because it may interfere with 
MALDI matrix crystal formation.  Using another glass micropipette filled with MALDI 
matrix, nanoliter volumes of matrix can be applied to single cells by gently touching the tip 
to the surface, where spot sizes less than 50 µm are achievable.  It is especially important to 
conduct multiple controls when such small samples are analyzed.  For example, the 
extracellular solution should be analyzed as a control to make sure that the detected signals 
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are truly coming from the studied cells and not the extracellular media, which may be 
contaminated by compounds from damaged cells. 
 
2.2.1.2 Recent Applications of Single-Cell MALDI 
To date, most single-cell MALDI reports relate to the investigation of the nervous system, in 
part because of the interest in understanding the cell-to-cell differences in key compounds in 
neurons.  There have been multiple reports of single-cell MS of the molluskan nervous 
system, demonstrating peptide identification in these samples via MS/MS.6, 31  Recently, 
similar work has been applied to insect neurons.  For example, specific neurons from 
Drosophila melanogaster, with 10–20 µm diameter somas, were identified by cell-specific 
expression of fluorescent protein, isolated, profiled with MALDI MS, and several peptides 
identified from these single cells.10  Moreover, previously unknown peptides can be 
discovered by detection and identification by MS/MS in various organisms.  This approach 
also helps to elucidate peptide processing and post-translational modifications that may be 
present.  In terms of peptide discovery in other organisms, the first MS-based identification 
of a prohormone from the arthropods Ixodes ricinus and Boophilus microplus was 
accomplished recently using single-cell analysis; these ticks have neurons smaller than 30 
µm.32 
In the Sweedler group, single-cell MALDI research has ranged from detecting 
peptides from Aplysia californica in single isolated organelles33 to spatial profiling of a 
single neuron34 to quantifying peptides in individual cells35. These experiments have resulted 
in the discovery of a number of new neuropeptide prohormones,36-39 as well as information 
on unique peptide post-translational modifications.5, 40-41  Moving toward smaller cell types, 
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single mammalian cells from the rat pituitary have also been analyzed, where approximately 
ten peptides were detected per cell, with more than 15 observed overall.29  As seen in Figure 
2.2, there is relatively high signal intensity from a single cell.  While the identities of many 
peaks in the mass spectra have been determined, there are other detected analytes that await 
identification.  This methodology can be applied to other cell types in other tissues and 
organs. 
A limitation of direct single-cell analyses via MS has been quantitation, although this 
is beginning to be addressed.  Quantitative measurements directly from tissues with MALDI 
are inherently difficult, in part because the incorporation of the analyte into the matrix needs 
to be reproducible among samples and the matrix spot should be homogeneous to ensure 
even analyte distribution and reproducible ionization.  Despite the inherent challenges of 
analyte quantification in cells with MALDI, a relative quantitation protocol has been 
developed using single Aplysia neurons.35  As shown in Figure 2.3, iTRAQ reagents were 
implemented to relatively quantitate components present within the cell.  The differences in 
analyte concentrations among different cells are revealed in the MS/MS data.  This protocol 
could certainly be implemented in other cell types to aid in functional studies. 
Another exciting technological advance that has been applied to single cell studies is 
mass spectrometric imaging (MSI).  MSI allows one to visualize the spatial distribution of 
many analytes within a particular sample and is a growing field in bioanalytical MS.42-44  In 
MALDI MSI, the sample stage is moved in small increments so that the laser ionizes each 
spot, thereby acquiring mass spectra at an array of locations across the sample surface.  
Images of specific analyte distributions in the sample are created by extracting the signal at a 
particular mass as a function of the spatial positions of the sample stage.  The spatial 
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distribution of many analytes, in some cases hundreds, can be determined in a single 
experiment; however, MALDI imaging at the single-cell level is problematic because of 
limitations in the spatial resolution of MALDI MSI.  Spatial resolution is determined by the 
laser spot size, the movement of the sample stage, or spreading of analytes.  For optimal 
sensitivity, it is important to extract the analytes from the cell and fully incorporate them into 
the matrix.  To achieve optimal spatial resolution, one needs to reduce analyte spreading 
because it reduces analyte extraction.  Accordingly, spatial resolution and sensitivity are 
linked.  Addressing this issue, Monroe, et al.45 developed a protocol whereby tissue sections 
are placed onto the surface of a layer of 40 µm glass beads embedded in Parafilm M.  When 
the substrate is stretched, each bead has on the order of a single cell attached to it.  After 
matrix is applied to the sample, recrystallization of the matrix enhances the quality of the 
matrix crystals.  Furthermore, due to the hydrophobic nature of Parafilm M, analyte 
redistribution is minimized.  Instead of trying to profile each individual bead, the entire 
sample can be profiled and the data stitched together to reconstruct an image of analyte 
localization from the original tissue sample.46  
Another approach using MALDI MSI on the cellular scale has been introduced by the 
Heeren group.47-48  Rather than decreasing the size of the laser spot to increase spatial 
resolution, a mass-microscope uses a large laser spot, but the spatial orientation of the ions is 
maintained during separation in the mass analyzer.  This technique is capable of a spatial 
resolution of 4 µm with 500 nm pixel sizes.  Although single-cell detection was not 
demonstrated, the scale for single-cell ionization and detection certainly has been achieved.  
MSI has also been employed in measuring time-resolved release of peptides from 
neurons using a microfluidic-based collection approach.49  In this work, a single Aplysia 
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neuron is confined inside a channel where three connected channels are used to collect 
releasates from a neuron before stimulation, during chemical stimulation, and post-
stimulation.  Each channel is also functionalized with a C18 layer to collect the released 
analytes.  This approach for temporal isolation of released peptides could be further 
improved by including additional channels for better temporal resolution. 
As mentioned previously, MALDI MS is more commonly used for detection and 
identification of larger molecules, but metabolites can also be studied with this approach.  As 
an example, metabolites in yeast were detected with single cell sensitivity by the Zenobi 
group.50  As noted in the supplementary material of their report, several sample protocols and 
optimizations were employed to increase sensitivity.  The optimized protocol included 
measuring the number of cells within a certain volume with flow cytometry and performing a 
cell extract on that sample.  Matrix was sprayed onto a target and the extract of various 
volumes was spotted onto it with a piezo printer.  It was determined that 390 pL was 
sufficient for obtaining metabolite signal from the extract, while the volume of a single yeast 
cell contains less than 100 fL.  Although not specifically single-cell MALDI, these results 
demonstrate that small cells and their small molecule contents can be assayed using this 
approach. 
Without a doubt, the figures of merit for single-cell MALDI MS are currently 
impressive, and they continue to be improved.  As enhanced sample preparation protocols 
and more sensitive instruments are developed, the efficacy of such measurements will 
progress.  This will allow a greater range of analytes to be measured from more cell types at 
higher spatial resolutions.  High throughput analyses of individual cells using MALDI MS 
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will expand applications of the technique to include fundamental research, clinical studies, 
and industrial investigations. 
 
2.2.2 Secondary Ion Mass Spectrometry 
Like MALDI, SIMS can directly profile samples and has been applied to single-cell studies. 
As one major difference, SIMS typically does not require the addition of a specific matrix to 
the sample. The ionization process for SIMS utilizes an energetic, focused ion beam to 
sputter secondary ions from the sample surface (Figure 2.1B).  This technique is considered a 
"hard" ionization technique, which produces internal fragmentation of analyte molecules.  
SIMS is implemented for smaller molecular weight compounds, with the majority of detected 
analytes having molecular masses less than 500 Da.  The upper mass threshold is limited by 
the sputtering and desorption processes of SIMS because the ejection of intact molecules is a 
lower probability event for larger molecular weight compounds.  Thus, the high mass limit 
depends on the amount of material present, as well as the sampling and sputtering processes. 
There are two modes of operation with SIMS: static and dynamic.  Static SIMS can generally 
be considered as a non-destructive method because less than 1% of the surface is probed by 
the primary ion beam.51  In contrast, dynamic SIMS uses a large number of primary ions 
where the surface layer is generally damaged and removed during analysis.52  Experiments 
using this method are also known as depth-profiling studies. 
A variety of ion beams can be implemented for sputtering with the analytical figures 
of merit dependent on the details of the ion beam.  Atomic and diatomic sources available 
include Au+, Ar+, Cs+, Ga+, In+, N2+, and O2-, but the use of cluster ion sources, such as C60x+, 
SF5+, Arnx+, CsnIy+, Binx+and Aunx+, are becoming more popular.  Cluster ion beams have 
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gained increasing attention because they generate higher secondary ion yields with greater 
efficiencies than atomic sources, improving the limit of detection for larger molecules while 
also decreasing sample damage.  One of the more impressive advantages of using SIMS is 
that analyte distribution can be imaged within a single cell, with spatial resolutions less than 
50 nm possible.53  SIMS has also been implemented in three-dimensional (3D) molecular 
analysis, where the ion beam initially rasters across the surface, generating secondary ions.  
A sputter beam removes this analyzed layer, thus exposing a new layer for further analysis.  
A detailed description of cluster sources, and their application to depth imaging, can be found 
elsewhere.54  
Another difference between MALDI and SIMS is that MALDI detects cellular 
content, and SIMS, as a surface technique, characterizes analytes on the cell membrane.  
Because of the fragmentation that occurs with the SIMS process, the detected analytes are 
typically identified by characteristic mass fragments and their comparison to standards.  
MS/MS analyte identification is not common, but has been developed.55-56 
 
2.2.2.1 Sample Preparation for Single-Cell SIMS 
Most studies that employ SIMS for single-cell analyses are interested in its imaging 
capability; thus, the overall goal of sample preparation in SIMS is preserving the original 
localization of analytes to obtain a representative view of processes occurring in functioning 
biological systems.  Freeze-fracture procedures for sample preparation are used because the 
process is rapid and preserves cellular morphology.57  However, this protocol tends to yield 
few cells for analysis and requires a specially designed cryochamber for sample handling. 
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Although inorganic salts can be imaged with SIMS, these salts can interfere with the 
detection of other analytes. If salt is present, which is common for cellular samples, it can 
dominate the spectrum.  Ammonium acetate can be employed to remove salt and other 
interferants from the cell while still maintaining the integrity of the cell membrane in a 
reproducible fashion.58  Furthermore, multiple fixation techniques can be used, such as 
rinsing the sample in water,59 70% ethanol,60 trehalose and glycerol,61 or sucrose and water.22 
Other sample preparation steps have also proven useful for improving signal with 
SIMS.  Charging can commonly occur, which results in poorly resolved peaks.  To alleviate 
this, a cell can be deposited or cultured on silicon, rather than on glass, or the entire sample 
can be coated with a thin layer of gold.22  This sample coating provides the additional benefit 
of increasing secondary ion yields with less fragmentation.  It has also resulted in the 
detectability of larger analytes; however, the resulting spectrum may include metal adducts 
and clusters, which can hamper data analysis.  Adding a MALDI matrix for SIMS application 
has also been demonstrated to increase the detectable mass range, but has not yet been 
implemented for single cell applications.  
 
2.2.2.2 Recent Applications of Single-Cell SIMS 
Measuring analyte distribution in cells can yield information not only on the state of the 
tissue, but also on the role of these molecules in various processes.  With the demonstration 
that SIMS was capable of imaging diffusible ions on a subcellular level, it was appreciated 
that a variety of biological processes could be monitored.62  For example, imaging of boron 
has been useful in determining cellular uptake in normal and tumor tissue for applications in 
cancer therapy.63  Furthermore, with the progression of SIMS instrumentation, molecular 
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species could be detected and imaged simultaneously with atomic species on a subcellular 
level, which led to its application in biological samples.64  
More recently, research has focused on membrane lipids and their changes during 
dynamic events.  As one example, Tetrahymena thermophila is a single-cell organism that 
mates by adjoining two cells to allow the migration of micronuclei between them.  This 
process requires lipid synthesis and rearrangement.  Winograd and Ewing’s65 groups 
demonstrated that the micron-sized junction between the two cell bodies has a decrease in 
phosphatidylcholine relative to the rest of the cell body.  Furthermore, the appearance of an 
unidentified peak increased in this junction, which was not present in other cell types and 
may be significant in forming this connection.  In another application of determining analyte 
localization, Monroe, et al.66 demonstrated that vitamin E is not homogeneously distributed 
in an Aplysia neuron but is found at higher levels at the soma-neurite junction. 
   Similar to MALDI MS, quantitation of analytes in a tissue requires attention to detail 
in SIMS.  The resulting signal intensity depends on the chemical composition and 
topography of the cell, primary ion interactions, instrumental transmission, and detector 
response.52  Ostrowski and coworkers67 developed a method to relatively quantify cholesterol 
between control and cholesterol-treated cells.  Cholesterol has a variety of roles, including 
functions in metabolism, controlling phase behavior of membranes, and being a precursor to 
hormones and vitamins.68-69  Also, abnormalities in cholesterol content have been observed in 
several diseases.70-72  The use of an internal standard that remains constant in treated and 
non-treated cells is needed for normalization of the spectra; in this case, C5H9+ was used.  
The control and cholesterol-treated cells were separately incubated with two different 
fluorophores known to adhere only to the outer membrane of the cell.  To make a direct 
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comparison, results for two cells under different treatments were analyzed in the same SIMS 
image to control for potential instrumental differences.  Different fragments of cholesterol 
were produced with varying degrees of cholesterol elevations and standard deviations in 
signal, results which stress that fragment ions must be analyzed and chosen carefully for 
accurate quantitation.  This methodology was able to detect a significant increase in 
cholesterol after incubation and could be applied for relative differences in concentration for 
other treatment conditions. 
 An enhancement to single-cell SIMS is 3D imaging.  An early demonstration is the 
imaging of Xenopis laevis oocytes,59 large cells (0.8–1.3 mm in diameter) that also contain 
larger cellular components.  These cells are also resistant to osmotic changes, which limits 
potential analyte diffusion.73  Different component localizations were detected in the x, y, 
and z planes of this model system, as shown in Figure 2.4, top panel, where some analytes 
have greater intensities below the cell plasma membrane.  Even though these cells are 
resistant to osmotic changes, they did exhibit a morphological change after rinsing with water 
and after freeze-fracture.  Sample preparation will need to be optimized to maintain the 
original morphology and distributions of analyte. 
In another example of 3D SIMS imaging, a new SIMS instrument design, the 
Ionoptika J105 3D Chemical Imager, incorporates a continuous C60+ ion source.55  This 
results in continuous secondary ion production, which greatly enhances the duty cycle and 
SIMS signal.  A pre-cooled sample stage is also included for flash-frozen samples to 
minimize analyte redistribution.  The resulting chemical image is shown in Figure 2.4, 
bottom panel, where adenine is localized in the center of the cell and the lipid signal is on the 
outer portion of the cell, as would be expected.  These demonstrations of 3D-imaging yield a 
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more complete view of cellular analyte distribution and will certainly lead to future 
applications in functional studies. 
Further enhancements to SIMS instrumentation continue.  Mass resolution 
improvements to the previously mentioned J105 3D chemical imager provided MS/MS 
capability,55 resulting in the ability to distinguish two different species with similar molecular 
weights. For example, analytes with m/z values of 102.8 and 103.0 had different spatial 
distributions in cheek cells.  In another advance, an Applied Biosystems QStar mass 
spectrometer with MS/MS capability has been modified and converted into a SIMS 
instrument by adding a C60 source.56, 74  With the development of new systems for analyte 
identification, SIMS implementation in bioanalytical investigations will become more 
frequent. 
Developments in SIMS have been primarily focused on sample preparation 
improvements, ion source development, and demonstrations of different capabilities of 
instrumentation, while actual functional bioanalytical studies have been somewhat limited.  
Given the high spatial resolution that SIMS affords, future studies should progress the field 
with more functional applications.  In one report, bacterial metabolism rates of carbon and 
ammonium were detected and quantified with SIMS on a single-cell basis via incubation of 
the cells with 13C and 15N.75  It was demonstrated that a high variability in metabolism 
existed between three different strains from a common environment, each having their own 
purpose.  Variability in metabolism was also detected in cells from the same strain.  Studies 
such as these can further our knowledge of bacteria and how they interact with the 
environment.  Other applications, such as imaging RNA localization with respect to 
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translation76 or tracing copper intake of algae for environmental monitoring77, offer data 
important for both fundamental and applied sciences. 
 
2.2.3 Electrospray Ionization 
ESI MS has been successful in characterizing a range of samples and is the preeminent 
approach for proteomics.  Interestingly, it is not routinely used in single-cell analysis.  Unlike 
MALDI and SIMS, ESI involves the use of liquids and therefore requires analyte extraction 
from the sample prior to introduction into the mass analyzer. Therefore, sampling, extraction, 
and analyte dilution are important in this application.  Once the sample is prepared, the 
analyte solution is electrosprayed (Figure 2.1C).  ESI yields multiply-charged species for 
larger molecules, with the same species being detected at different m/z values, often reducing 
detection limits.  Separation techniques, such as liquid chromatography or capillary 
electrophoresis (CE) are commonly hyphenated to ESI to reduce sample complexity and to 
concentrate analyte bands.  Because ESI is not as tolerant to many inorganic salts and organic 
additives as are SIMS and MALDI, the separations also serve to desalt and condition the 
samples prior to measurement.   
Nevertheless, ESI has the capability to detect a broad range of analytes from a single 
cell, from metabolites to large proteins, especially when optimized sample preparation 
approaches are implemented.  There are multiple commercial nanospray ESI sources 
available, which are important as these minimize sample consumption and therefore fit well 
with single-cell ESI MS.  With such approaches, the sensitivity and limits of detection for 
ESI MS instruments are sufficient for the detection of analytes from single cells.78  
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2.2.3.1 Recent Applications of Single-Cell ESI 
Most reports of single-cell ESI include hyphenation to CE, which separates analytes based on 
their size and charge with high efficiency.  Using this combined approach, hemoglobin was 
detected in human erythrocytes, where it is found at high levels.79  The cell was directly 
injected into the capillary with no prior stabilization and then lysed due to the osmotic 
pressure difference of the running buffer.  Similar results were obtained on single 
erythrocytes using a different mass analyzer, thus demonstrating capability on multiple 
instrument platforms.80  Other analytes, besides proteins, can be studied using single-cell ESI 
MS as well.  Preliminary results reported by Lapainis, et al.81 demonstrate that characterizing 
a single neuron from A. californica for metabolite content is possible.  To achieve these 
results, a home-built CE system was interfaced with ESI MS and an experimental protocol 
was developed.  Several substances were detected, including acetylcholine. 
Recently, there was a report of single-cell ESI MS with mammalian cells without the 
need for prior separation.82  The nanospray tip was implemented as a micropipette under a 
video microscope, where the cytoplasm or granules were removed from the cell (Figure 2.5).  
Ionization solvent was added to the tip, and the sample directly introduced into the mass 
spectrometer.  The cytoplasm, cell medium, and solvent had similar, but distinct profiles.  
Principal component analysis was applied to the data from each sampling, where data points 
from each sample set were all clearly separated (Figure 2.6).  Several peaks were also 
identified by MS/MS, such as histamine and serotonin.   
Single-cell ESI MS certainly has unrealized potential.  Separations prior to ionization 
allow more complex samples to be measured and so protocols need to be optimized for each 
sample and analyte of interest.  Direct infusion with ESI is advantageous because sample 
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dilution is minimized and analysis times are much shorter.  With the large range of analytes 
that can be detected and identified with ESI MS, efforts to improve sample introduction 
approaches will continue. 
 
2.2.4 Other MS Approaches 
MALDI, SIMS, and ESI are the most widely used ionization techniques for MS 
investigations of biological samples and single-cell studies.  However, it is worth mentioning 
several of the other MS techniques that are becoming more prominent and have potential in 
this area.  Some are related to laser desorption/ionization (LDI), which does not require a 
matrix for ionization.  For example, with the pioneering work of Hillenkamp83 in the 
development of laser microprobe mass analysis (LAMMA), spatial resolution can be on the 
micron scale and a variety of small analytes can be detected.84  Desorption/Ionization on 
porous silicon (DIOS) can ionize peptides from single neurons and has the capability to 
image small molecules from single cells.60, 85  A recent development is nanostructure-initiator 
mass spectrometry (NIMS), which utilizes a laser or an ion beam to ionize samples on a 
substrate embedded with clathrate structures to promote ionization.86  This technique 
produces little fragmentation, has a lateral resolution of 150 nm, and has already achieved 
single-cell detection.  Laser ablation electrospray ionization (LAESI) combines an ablation 
plume with ESI-like ionization, where plant tissue can be directly ionized and imaged.87-88  
This technique currently has a 200–300 µm spatial resolution with fmol level detection 
limits.  
Like LAESI, there are other ambient ionization methods that have been developed as 
well.89  Desorption electrospray ionization (DESI) utilizes a charged spray to extract and 
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ionize analytes directly from the sample surface, and has already been implemented in 
imaging tissue sections for metabolites and lipids.90-91  Another example is direct analysis in 
real time (DART), which uses reactive ionized species to interact with the sample of interest 
and is beginning to be used on biological samples.92-93  While this is not a comprehensive list 
of techniques that have the potential for single-cell MS detection, it indicates the power of 
these emerging methodologies for direct tissue measurements. 
 
2.3 Overall Outlook for Single-Cell MS 
The implementation of single-cell MS has been useful in studying neuronal systems, 
metabolic profiles, cell membrane components, and many other systems and analytes.  
MALDI, SIMS, and ESI are complementary techniques that yield a wealth of information 
about the presence of identified and novel analytes.  With the currently available sample 
preparation and signal acquisition protocols, as well as instrumentation, many biological 
questions can be answered.  Continuing to develop quantitative approaches is key to 
understanding the relationships between analytes.  Incorporating MSI in these studies aids in 
determining what roles are being played by individual cells within a cellular network.  The 
rapid growth of a plethora of sampling and ionization approaches that offer a new range of 
capabilities is also exciting.  The rapid evolution of technology with the increasing role of 
proteomic and metabolomic investigations certainly proves that single-cell MS is an area of 
growth.  It is expected that further applications and discoveries will expand over during the 
coming decades. 
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CHAPTER 3 
 
MS-BASED METHODOLOGIES FOR SINGLE-CELL METABOLITE DETECTION 
AND IDENTIFICATION 
 
Notes and Acknowledgments 
This chapter outlines protocols used for single-cell metabolite detection and is based on a 
chapter submitted as “MS-based methodologies for single-cell metabolite detection and 
identification” in Methodologies for metabolomics: experimental strategies and techniques, 
Sweedler, J. V., Ed. Cambridge University Press: 2011 with coauthors Peter Nemes, 
Stanislav S. Rubakhin, and Jonathan V. Sweedler.1  It is reprinted here with the permission of 
Cambridge University Press.  Peter and I focused on sections specific to CE-ESI-MS; I wrote 
sections including the introduction, materials, data analysis methods, and conclusion, while 
Peter wrote the methods and procedures section.  Stanislav wrote sections specific to MALDI 
MS. The entire protocol is reproduced here for completeness.  The authors would like to 
thank Xiying Wang for assistance in the single-cell sample preparation. This work was 
supported by the National Science Foundation (NSF) under Award Number CHE-0526692 
and the National Institutes of Health (NIH) under Award Numbers DK070285, NS031609, 
and U54GM093342. 
 
3.1 Introduction 
This chapter describes detailed protocols required for single-cell metabolomics.  
Metabolomic studies strive to determine the small molecule composition (e.g., sugars, lipids, 
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amino acids, but not peptides, proteins, DNA, and RNA) of a biological sample in a given 
state.  Information generated from the sample, which is often complementary to gene 
expression and proteomic data, serves to link chemical content to the observed phenotype.  
For example, metabolomics is often used to examine metabolic differences between a control 
and an altered state, such as normal and diseased.2-4  Metabolites are typically measured in 
complex, multicellular biological sample matrices—blood, serum, urine, and tissue biopsies.  
Moreover, there can be a diversity of cell types present within these specimens; for instance, 
brain tissue consists of neurons, glia, and other cell types.  Furthermore, cell-to-cell 
heterogeneity is known to exist, even within the same cell type,5-9 especially in the nervous 
system10-12.  To improve the fundamental understanding of the underlying biochemistry of 
biological systems, chemical analysis is beneficial when performed at single-cell levels.   
Significant technology advances for single-cell analysis, and understanding their 
crucial role in answering biological and medical questions, have resulted in their widespread 
applications in the metabolomics field.13-15  For example, electrochemical detection is a 
highly sensitive technique that has been applied to monitoring cellular exocytosis and 
secretion.16-20  Fluorescence detection is also suitable for single-cell investigations and has 
been implemented to study the metabolism of particular pathways by fluorescently tagging 
an analyte of interest within a cell and observing the resulting enzymatic products.21  Single-
cell separations have also been accomplished using capillary-scale separations with 
electrochemical and fluorescence detection, enabling the characterization of multiple 
analytes.22-23  Mass spectrometry (MS) is a particularly attractive method of single-cell 
microanalysis because a priori knowledge of analyte content is not necessary and many 
analytes can be simultaneously detected.  In addition, the combination of accurate mass 
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measurements and tandem mass spectrometry (MS/MS) provides a straightforward system to 
confidently identify metabolites.  MS also has the required sensitivity, limits of detection, 
and dynamic concentration range for single-cell metabolomics applications.  While the depth 
of metabolome coverage will decrease when scaling down from tissue homogenates to 
single-cell samples, the advantage is the capability to analyze heterogeneity on a single-cell 
level.  For recent reviews regarding single-cell MS, the reader is referred elsewhere.24-25   
Traditionally, two ionization sources have been particularly successful in single-cell 
MS: matrix-assisted laser desorption/ionization (MALDI) and electrospray ionization (ESI).  
In the former method, the sample is mixed with an infrared or ultraviolet-absorbing 
compound (matrix) to help generate analyte ions in vacuum.  MALDI has been incredibly 
useful in detecting analytes, such as peptides, in single-cell applications and has been utilized 
for this purpose for approximately the last 15 years.26-27  More recently, MALDI has been 
used in metabolite detection; for example, it has been implemented to profile metabolite 
differences in unicellular organisms, with applications in determining how organisms 
respond to different environments and stimuli.28  In an effort to achieve high-throughput 
analysis in single cells, a protocol has been developed to create patterns of single yeast cells 
for subsequent MALDI analysis.29  In ESI MS, analytes are first extracted into the liquid 
phase and then converted into gas-phase ions by an electrospray source.  When coupled to 
capillary electrophoresis (CE), ESI MS enables the detection and identification of a number 
of metabolites in single cells and subcellular features.30  Both ionization sources are 
beneficial for the analysis of biological samples because they can ionize a wide range of 
intact analytes, from metabolites to large proteins.   
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Several other ionization techniques have been coupled with MS for metabolite 
detection in single cells.  Laser ablation electrospray ionization (LAESI)31 is a relatively new 
ionization technique that has been implemented to directly analyze metabolites from single 
plant cells with no sample preparation32.  Single-cell video-MS can be used to investigate 
metabolites from cells and their subcellular features; cellular contents such as the granules 
from mast cells were collected intracellularly with an electrospray emitter and directly 
electrosprayed into the mass spectrometer.33  Subcellular analysis and spatial imaging can be 
achieved with ionization techniques such as secondary ion mass spectrometry (SIMS)34 or 
nanostructure-initiator mass spectrometry (NIMS)35.  While gas chromatography (GC)-MS 
has been routinely used for metabolomics approaches with multicellular samples, it may have 
been the first MS approach used for single-cell analysis, specifically, of neurons from 
Aplysia californica.36  More recently, GC-MS has demonstrated its applicability in single-cell 
analysis with the detection of over 400 low mass signals from single oocytes.37  For more 
extensive reviews of applications in single-cell metabolomics, the reader is referred 
elsewhere.1, 38-39   
Here, MS strategies are presented using MALDI and CE-ESI to investigate the 
chemical composition of individual neurons in the nervous system of A. californica, a 
common neurological model.  The MALDI MS protocol enables the direct analysis of 
nanoliter-volume samples and provides immediate feedback about the sample content.  The 
CE-ESI-MS method described provides complementary information on metabolite coverage 
and enhances the confidence of chemical identifications by incorporating chemical 
separation.  With hundreds of metabolites detected, these protocols allow the routine analysis 
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of individual neurons, and with some modification, these approaches can be applied to other 
cell types.   
 
3.2 Methodologies: Overview and Timing  
The general workflow for MS-based metabolite measurements in individual cells is shown in 
Figure 3.1.  Initially, the organism of interest is anesthetized (if needed), dissected, and the 
tissue optionally treated with an enzyme, in part to reduce connective tissue that surrounds 
the cell(s) of interest to loosen or remove its contact between the cells.  Individual cells are 
then isolated, a task for which micromanipulators can provide excellent reproducibility.  
Depending on the goal of the study and the applied detection method, cells can be exposed to 
different degrees of chemical modification during and after the isolation step.  For example, 
delicate cells can be isolated in a glycerol-containing environment, which enters the cells and 
mechanically stabilizes them, thereby preventing unintentional cell lysis.40-42  Following 
isolation, cells may be rinsed with a small amount of water to remove extracellular organic 
compounds and inorganic salts.  Lowering the concentration of nonvolatile salts in the 
sample extract can improve analyte ionization in both MALDI and ESI experiments, which 
can in turn improve detection limits for metabolite measurement.   
A variety of MALDI matrixes can be used for metabolite detection.  The compound 
2,5-dihydroxybenzoic acid (DHB) is particularly useful because it allows the ionization of 
small metabolites and larger molecules (e.g., peptides) from the same prepared sample.  
Furthermore, it can also enable detection of analytes under salty conditions and act as a 
stabilizing agent for cell samples.26  Other MALDI matrixes that can be employed in single-
cell MS metabolomics investigations include 9-aminoacridine43-44 and alpha-cyano-4-
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hydroxycinnamic acid45.  In some cases, the MALDI matrix can be eliminated and a focused 
laser beam can be used to desorb and ionize molecules directly from samples in vacuum, an 
approach called laser desorption ionization.46  For MALDI MS experiments, the sample may 
be directly spotted on a substrate, co-crystallized with a suitable matrix, and after air- or 
vacuum-drying, analyzed or chemically imaged.   
In contrast to single-cell MALDI MS, analytes are typically extracted and diluted in a 
suitable solution prior to ESI analysis.  This minimizes or eliminates potential interferences 
with the ESI process, such as cell debris and salt, and provides a well-controlled chemical 
environment for the study of selected analytes.  The extraction solution of choice should also 
hinder, or ideally prevent, degradation or formation of metabolites in enzymatic reactions.  
To obtain optimal extraction efficiency, the composition of the solution must be tailored to 
the physicochemical properties of the compound(s) of interest, including the size, polarity, 
and net charge of the molecule.  Permanently charged compounds (e.g., potassium+, choline+, 
and acetylcholine+) and zwitterionic structures (e.g., amino acids) are readily incorporated 
into water, whereas apolar molecules can be extracted with higher yields in the presence of 
organic modifiers (e.g., methanol and acetonitrile), which should be tested for compatibility 
with ESI or CE-ESI processes.  The efficiency of extraction can be further adjusted by 
altering the solution pH.  For small metabolites, aqueous organic solvents containing acidic 
or basic pH-modifiers have been successfully applied.30  
The addition of a chemical separation step prior to direct MS detection can often be 
advantageous.  Not only can separation aid in the detection of isobaric compounds, but the 
analyte elution time also provides additional information to confirm identification.  There are 
several fundamental reasons why CE is a method of choice for the separation of various 
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compounds in single-cell investigations: high-efficiency, compatibility with relatively salty 
samples, small injection volumes (nL), the availability of a number of CE-based analyte 
concentration techniques, and applicability for a wide range of molecules (molecules do not 
necessarily need to be charged).22-23, 47-48  One critical element of CE and MS hyphenation is 
that the composition of the background electrolyte must be compatible with the operating 
conditions of ESI.  To further facilitate hyphenation, a coaxial sheath-flow CE-MS interface 
achieves the analytical performance required to detect neurotransmitters from a single 
neuron.30, 48   
The following sections provide guidance in the selection of materials and procedures 
to enable metabolic analysis of single cells.  The analytical steps presented here can be 
further optimized for a particular cell type, tissue, or animal of interest.  Here, the following 
protocols apply to the investigation of isolated cells from the central nervous system (CNS) 
of A. californica and the detection of metabolites below m/z 1,000.   
 
3.3 Materials  
3.3.1 Sample Preparation  
3.3.1.1 Animals  
A. californica weighing 175-250 g can be obtained from The National Resource for Aplysia 
(Rosenstiel School of Marine and Atmospheric Science, University of Miami/NIH, FL; 
http://aplysia.miami.edu/) and should be maintained in constantly circulated, aerated 
seawater chilled to 14 °C.  Artificial seawater for use in the aquarium can be made in the 
laboratory by dissolving sea salts (Instant Ocean; Aquarium Systems, Mentor, OH) in water 
according to the manufacturer’s instructions.  While well-suited for animal maintenance, this 
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type of artificial seawater is not recommended for analytical measurements because the exact 
ion composition is not defined.   
 
3.3.1.2  Reagents and Solutions 
The chemicals and reagents used in these protocols were from Sigma-Aldrich (St. Louis, 
MO) unless otherwise noted.   
 Chemicals: Water (LC-MS grade Chromosolv®), methanol (Optima®, Fisher 
Scientific, Fair Lawn, NJ), formic acid (FA) (99+%, Thermo Scientific, Rockford, 
IL), acetic acid (99+%), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) (99.5%), DHB (98%), ammonium citrate (99.7%, Fisher Scientific), ethanol 
(99.5%, Acros Organics, Morris Plains, NJ), phosphoric acid (85%, EM Science, 
Gibbstown, NJ), and water with 0.1% FA and 0.01% trifluoroacetic acid (TFA) (v/v) 
(Fisher Scientific).  
 Artificial seawater (ASW) supplemented with antibiotics: (mM) 460 NaCl, 10 KCl, 
10 CaCl2, 22 MgCl2, 26 MgSO4, and 10 HEPES (pH 7.7), 100 units/mL penicillin G, 
100 μg/mL streptomycin, and 100 μg/mL gentamicin.  
 Enzyme solution: 1% protease type IX in ASW supplemented with antibiotics.  
 Solution for cell stabilization: 33% glycerol with 67% ASW (v/v).  
 Extraction solution for analyte sampling: 50% methanol containing 0.5% acetic acid. 
 MALDI standards: serotonin, aspartate, glutamate, alanine, and serine.  
 
3.3.1.3 Disposables 
 PCR vials (MidSci, St. Louis, MO). 
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 Sharp metal needles (World Precision Instruments (WPI), Inc., Sarasota, FL). 
 Glass Petri dishes for cell isolation that are half-filled with Sylgard (Dow Corning, 
Midland, MI). 
 
3.3.1.4 Equipment 
Visualization system: high-performance stereoscope with 7.9:1 zoom (e.g., similar to the MZ 
7.5, Leica Microsystems Inc., Bannockburn, IL) and optional digital camera for recording. 
 
3.3.2 CE-ESI-MS System 
3.3.2.1 Reagents and Solutions 
 Background electrolyte for CE separation: 1% FA.  
 Electrospray solution: 50% methanol prepared with 0.1% FA. 
 
3.3.2.2 Equipment 
 Regulated high-voltage power supply (HVPS) capable of at least 20 kV output with 
optional remote-programmed operation, similar to the Bertan 2320 series (Spellman 
High Voltage Electronics Corporation, Valhalla, NY) or Glassman PS/MJ series 
(Glassman High Voltage, Inc., High Bridge, NJ). 
 Injection stage capable of elevating a platform 15 cm within ~3 s and housing 
stainless steel vials for sample loading and the background electrolyte. 
 Enclosure equipped with an interlock system to provide protection against exposure 
to components kept at an elevated potential (e.g., stainless steel vials and fused silica 
capillary). 
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 Separation capillary: fused silica capillary with ~100 cm length and optimized 
dimensions (e.g., 40 µm inner diameter (i.d.), 105 µm outer diameter (o.d.), 
Polymicro Technologies, Phoenix, AZ). 
 Solvent-delivery PEEK tubing or capillary: ~50 cm length and optimized dimensions 
(e.g., 75 µm i.d., 105 µm o.d., Polymicro Technologies, Phoenix, AZ). 
 T-union and corresponding components (e.g., fittings, ferrules, and sleeves) to adapt 
the separation and solvent-delivery capillaries, e.g., stainless steel hypodermic tubing 
(211 µm o.d., 165 µm i.d., Small Parts, Inc., Miramar, FL), PEEK tee or MicroTee 
(Idex Health & Science LLC, Oak Harbor, WA).30 
 Three-axis translation stage (e.g. from Newport Corp., Irvine, CA). 
 Solvent-delivery system such as a syringe pump (similar to a PHD 22/2000, Harvard 
Apparatus, Holliston, MA) capable of supplying solutions at ~300-1,000 nL/min 
rates. 
 Gas-tight syringes for supplying the electrospray solvent and the background 
electrolyte, e.g., 1 mL gastight syringe (Hamilton Company, Reno, NV). 
 ESI mass spectrometer: The CE-ESI interface can be adapted to a number of mass 
spectrometers that feature an atmospheric pressure interface. The present protocol 
utilizes single-stage and tandem mass spectrometers for metabolic profiling and 
collision-induced fragmentation (micrOTOF ESI-TOF-MS and maXis ESI-Qq-TOF-
MS/MS systems, Bruker Daltonics, Billerica, MA). 
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3.3.2.3 Software 
 Software to process and analyze the recorded mass spectra (e.g., Compass, Bruker 
Daltonics). 
  (Optional) Software and equipment to remotely control the HVPS (e.g., LabVIEW- 
or MATLAB-based custom-written software). 
 
3.3.3 MALDI MS System 
3.3.3.1 Reagents and Solutions 
 MALDI matrix solution: 10 mg/mL DHB in a 79:20:1% 15 mM ammonium 
citrate:ethanol:concentrated phosphoric acid mixture.  
 Standards: 100 mM or saturated solutions of serotonin, aspartate, glutamate, alanine, 
and serine in 0.1% FA, 0.01% TFA in water.  
 
3.3.3.2 Equipment 
MALDI mass spectrometer: The protocols listed here use the ultrafleXtreme (MALDI 
TOF/TOF mass spectrometer) from Bruker Daltonics, which is optionally operated in single-
stage or MS/MS (LIFT) modes.49 
 
3.3.3.3 Software 
 Software to process and analyze recorded mass spectra (e.g., Compass, Bruker 
Daltonics). 
 (Optional) Software for multivariate analysis of MS data (e.g., ClinProTools, Bruker 
Daltonics).   
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3.4 Procedures and Troubleshooting 
3.4.1 Sample Preparation  
3.4.1.1 Single Cell Isolation 
1. Anesthetize the animal using vascular cavity injection with isotonic MgCl2 solution 
equal to one-third to one-half of the animal’s body weight. Dissect the ganglia of 
interest from the CNS of A. californica. 
2. Incubate the ganglia in 1% protease IX solution at 34 °C for 20-120 min depending 
on the cells that need to be isolated, ganglia type, animal weight, and season.  It is 
practical to optimize the duration of enzymatic treatment for the ganglia of interest.  
Wash the ganglia several times with fresh ASW to remove the enzyme after 
treatment.  
3. (▲Critical step) Pin down the ganglia on the Sylgard surface of a petri dish filled 
with ASW and mechanically isolate target neurons with sharp metal or glass 
needles.50  During this step, the solution for cell stabilization may be used to improve 
cell stability during mechanical stress.  Control measurements have demonstrated that 
this solution does not appreciably interfere with ion generation during MALDI or 
ESI.  
4. (Optional) Rinse the isolated cell with ~1 µL water using a pipette. 
 
3.4.1.2 Sample Preparation for CE-ESI-MS 
1. Place the neuron into 5 µL of extraction solution.  
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2. (Optional) Chemical standards may be added to the extraction solution for analyte 
quantitation and/or internal mass-calibration of the mass spectrometer.  The use of 
internal standards is particularly helpful when metabolic quantitation is desired. 
3. (■Pause point) (Optional) Store cells in the extraction solution at –20 °C for several 
days.  For long-term storage, utilize a freezer providing –80 °C to minimize metabolic 
degradation.  In both cases prolonged storage may result in sample drying and 
therefore liquid nitrogen storage can be considered. 
 
3.4.1.3 Sample Preparation for MALDI MS 
1. Place individual cells directly onto a stainless steel MALDI sample plate and apply 
0.3 µL of matrix solution on top of the cell; allow the matrix solution to dry at room 
temperature.  Alternatively, incubate the isolated cell in 3 µL of matrix solution 
overnight at 4 °C and deposit aliquots of controlled volume (e.g., 0.3 µL) on the 
sample plate in duplicate. 
2. Create two control spots by applying 0.3 µL of the matrix solution on the sample 
plate. 
3. Apply 0.3 µL of a mixture of standards, such as serotonin, aspartate, glutamate, 
alanine, and serine, on two spots and allow the solution to dry at room temperature.  
Add 1 µL of the matrix solution on top of the dried spot.  
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3.4.2 Instrument System Setup 
3.4.2.1 CE-ESI-MS 
1.  (▲Critical step) Prepare a CE-ESI interface using a T-union that incorporates an 
electrospray emitter on one end.  In the other end of the union, feed a fused silica 
capillary coaxially through the emitter.  Allow for this separation capillary to protrude 
~200-1,000 µm beyond the tip of the ES emitter and finger-tighten connections for a 
stable arrangement.  Use the third end of the T-union to supply the electrospray 
solvent through a fused silica capillary.  Further technical details on assembling a 
stable CE-ESI ion source are detailed elsewhere.30 
2. Mount the CE-ESI interface on a three-axis translation stage and position it ~10 cm 
from the skimmer of the mass spectrometer.  Ground the electrospray emitter directly 
or through the T-union. Inspect the setup for both electrical and mechanical stability. 
3. Using a syringe pump, supply the electrospray solution through the metal emitter at 
350-1,000 nL/min rate and simultaneously flush the background electrolyte through 
the separation capillary for 5-30 min upon first use (following assembly) and about 5-
10 min thereafter. 
4. (■Pause point) Stop the solution supply through the separation capillary and transfer 
its injection end into a vial containing the background electrolyte.  
5.  (▲Critical step) With respect to ground, apply ~1700 V on the skimmer of the mass 
spectrometer (labeled “Source: Capillary” for the micrOTOF and maXis systems) and 
position the CE-ESI interface within 5 mm from the skimmer or until electrospray is 
initiated. Using a stereomicroscope or by following the ion signal, finely adjust this 
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distance to ensure operation in the cone-jet spraying mode to achieve efficient ion 
generation.51 (? See Table 3.6, Troubleshooting Hint #1.) 
6. Leave ample time for the solvent-delivery and CE-ESI-MS system to reach physical 
and chemical stability, and inspect the CE-ESI interface for mass spectrometric 
stability over at least 10 min. (? See Table 3.6, Troubleshooting Hint #2.) 
7. (▲Critical step) Optimize the applied voltage applied to the capillary that provides 
the desired chemical separation and separation times for the metabolites of interest. 
Successful results can be obtained by increasing the potential difference from 0 kV to 
20 kV over ~15 s and keeping it constant thereafter.30  Controlling the HVPS via 
computer provides more reproducible voltage programs. 
8. Test the CE-ESI-MS system for analytical stability for at least 20 min. (? See Table 
3.6, Troubleshooting Hint #3) 
9. Lower the potential difference between the separation capillary ends from 20 kV (or 
that applied) to 0 V over ~15 s. 
10. Increase the MS skimmer-ES emitter tip distance to 5-10 cm or until electrospray 
ceases, and adjust the MS skimmer potential to 0 V with respect to ground. 
11. (■Pause point) Flush the background electrolyte through the separation capillary for 
at least 5 min. 
 
3.4.2.2 MALDI MS 
1. (Optional) Set a mass range for metabolites between m/z 20 and 1500.  The low 
boundary is set to include ion signal from sodium because it can be used as an 
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internal calibration point and is present in the majority of biological samples.  When 
DHB is used, the larger mass range enables simultaneous detection of peptides.  
2. Optimize instrument settings for sufficient metabolite detection at low concentrations 
for the mass range of interest.  Critical settings are laser beam intensity, laser focal 
point size, and pulsed ion extraction delay time.  
3. Save the optimized instrument method in the same directory where data from 
comparative analyses are going to be saved.  This organized arrangement ensures that 
the optimized instrumental settings are consistent with comparative analyses, which is 
critical.  
4. Optimize instrument settings similarly for MS/MS experiments using a variety of 
standards at different m/z values and save this method as in step 3 above.  
 
3.4.3 Single-Cell CE-ESI-MS Analysis 
1. (Optional) If the sample was kept frozen, allow ample time for the solution to defrost, 
and if needed, homogenize the sample extract mechanically (vortex).  Afterward, 
centrifuge the sample extract for 1 min at ~6,600 rpm to reduce cellular debris in the 
supernatant.  Cellular debris can have dimensions comparable with the inner diameter 
of the separation capillary and can clog it. 
2. Repeat step 7 from section 3.4.2.1, maintaining the separation potential at 20kV (or 
whatever voltage was used) for 2 min.  Afterward, proceed with step 9 from section 
3.4.2.1.  
3. Transfer a 200-500 nL aliquot of the sample extract into the sample-loading vial of 
the injection stage.  
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4. Position the injection end of the separation capillary so that it is in contact with the 
deposited sample extract in the sample-loading vial. 
5. (▲Critical step) While keeping the injection end of the separation capillary in the 
sample-loading vial, lift the stage 15 cm and keep it elevated for 60 s, gravimetrically 
injecting ~6 nL of the extract solution into the capillary. (? See Table 3.6, 
Troubleshooting Hint #4.) 
6. (▲Critical step) Lower the injection end of the capillary back to level with the outlet 
within 1 s, and within ~3 s, move the injection end of the capillary into a vial filled 
with the background electrolyte.  
7. (Optional) Elevate or lower the injection end of the capillary above or below the 
outlet end to apply positive or negative hydrostatic pressure during CE separation, 
respectively. 
8. Repeat step 7 from section 3.4.2.1 and simultaneously enable mass spectrometric data 
acquisition at a minimum 2 Hz spectral rate (preferably higher) and acquire mass 
spectra for the entire duration of the separation experiment.  If the mass spectrometer 
features a time limit, set it past the expected duration of the separation experiment. 
9. When the compounds of interest have eluted from the separation capillary, repeat 
steps 9-11 from section 3.4.2.1 to stop the experiment.  Small metabolites typically 
elute within the first 10-30 min of the separation, yet data are collected up to 50 min 
to enhance the metabolome coverage. 
 
3.4.4 Single-Cell MALDI-MS Analysis 
1.  (▲Critical step) Ensure the sample and standard spots are dry prior to loading the 
MALDI sample plate into the mass spectrometer.  This is important because the 
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evaporation of liquid will prevent the instrument from achieving high vacuum 
quickly.  If glycerol is applied for cell stabilization, place the samples under vacuum 
for at least 15 min prior to loading the sample plate.  
2. Load the prepared sample plate into the mass spectrometer. 
3. Calibrate the MALDI MS instrument using ion signals from the DHB matrix and 
sodium.  This can be performed directly on the single-cell sample.  However, external 
calibration is useful, especially with MS/MS data; if this is the case, the MALDI 
standard mix can be used.  
4. Save the calibration information as an individual file. 
5. (Optional) It is recommended to find the best type of sample surface for the analyte(s) 
of interest and conduct comparative analyses using this particular type of sample 
region.  MALDI matrix sample spots can be heterogeneous; depending on the 
MALDI matrix implemented, analyte, and location of the cell on the sample plate, 
different locations for the MALDI matrix spot can be explored in order to optimize 
signal intensity.  For example, the center of the sample spot containing a more 
amorphous and uniform DHB coating may produce better metabolite signals. 
6.  Acquire mass spectra from single-cell samples.  This can be done in a manual or 
automatic fashion. (? See Table 3.6, Troubleshooting Hint #5.) 
7. (▲Critical step) File compatibility with the data analysis software must be confirmed.  
This is imperative when working with software packages that originate from sources 
other than the instrument manufacturer. 
8. Choose or create a directory and save the results.  The structure of data directories for 
each set of experiments should be considered in advance for straightforward data 
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retrieval and processing, especially when multivariate analysis (e.g., using 
ClinProTools) is planned.  
 
3.4.5 Data Interpretation  
3.4.5.1 CE-ESI-MS Results 
1. Mass-calibrate the acquired data.  Internal mass calibration can be enabled by sodium 
formate clusters that form in situ in the electrospray source as sodium elutes from the 
separation capillary.  
2. Plot the extracted ion electropherograms (XIEs) for the ions of interest.  
3. (Optional) To identify the eluting compounds, generate XIEs across the entire 
acquired m/z range by a selected m/z width (e.g., m/z 50-500 range screened, + 500 
mDa).  Use automated data processing (e.g., a script) to decrease data processing 
time. 
4. (Optional) Use mathematic algorithms to filter noise and instabilities in the generated 
XIEs (e.g., 3-point Gaussian smoothing). 
5. Identify chromatographic peaks in each XIE and compile a list of eluting analytes.  
Data processing can be aided by implementing a peak-picking algorithm within the 
data analysis software.  Tabulate the accurate mass of each compound detected. 
6. (Optional) Plot XIEs for each detected accurate mass from step 5 above with a narrow 
mass-selection window (e.g., 5 mDa).  For quantitative analysis, determine the area or 
intensity of each detected compound using these generated XIEs.  
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7. (Optional) To enhance the confidence of metabolite identifications, in an independent 
CE-ESI separation experiment, perform MS/MS experiments for the ions tabulated in 
step 5 above. 
8. Identify detected compounds by comparing the accumulated molecular information 
(accurate mass, isotope distribution, migration time, and fragmentation behavior) with 
chemical standards and data available from metabolite databases, such as Metlin52 or 
MassBank53. 
 
3.4.5.2 MALDI MS Results 
1. Load acquired MALDI MS and MS/MS data into the data analysis software (e.g., 
FlexAnalysis). 
2.  (Optional) Use mathematical algorithms to filter the data and correct for shifts in the 
baseline.  However, the low mass range of the mass spectra typically is dominated by 
the most concentrated analytes and MALDI matrix signals, and the spectra typically 
do not require smoothing and baseline correction. 
3. (Optional) Recalibration can be done for MS and MS/MS data sets, which is an 
especially useful option when an uneven sample plate surface is employed.  
4. (Optional) Obtain a list of observed masses in the single-stage MS spectra to develop 
a list for future MS/MS experiments. 
5. Obtain mass lists for fragment ions present in the MS/MS data. This can often be 
accomplished manually. 
6. (Optional) Load MALDI MS data into a statistical software package (e.g., 
ClinProTools) for principal component analysis (PCA) if a comparison of complex 
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data sets is necessary.  PCA can highlight data points which have the largest variance, 
and therefore uncover analytes that contribute to differences between sample types. 
7. (Optional) To reduce the complexity of the data, implementing corrective factors, 
such as baseline subtraction, smoothing, data reduction, and automatic exclusion of 
noisy or empty mass spectra, can be useful.  
8. (Optional) Run PCA analysis.  
9. Compare obtained m/z values with data available in databases such as Metlin or 
MassBank to putatively assign identities to investigated compounds.  Fragmentation 
data can also be compared in these databases; however, most of the MS/MS data for 
metabolites stored in databases are from ESI rather than MALDI, so there may be 
some fragmentation differences.  
 
3.5 Exemplary Applications 
3.5.1 Metabolomics with Single-Cell CE-ESI-MS 
The protocols presented here facilitate metabolic investigations of larger individual cells, 
providing information on the cell-to-cell differences in metabolomes.  Various A. californica 
neurons have been isolated and chemically interrogated in the procedures described for CE-
ESI and ultraviolet MALDI MS experiments.  As these two methods apply slightly different 
sample manipulation steps and convert metabolites to ions via fundamentally different 
mechanisms, the metabolome coverage is expected to vary accordingly.  Figures 3.2 and 3.4 
showcase representative results for the metacerebral cell (MCC), R2, and LP1 neurons by the 
two respective methodologies, providing complementary sets of information.  
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With the single-cell CE-ESI-MS approach, a large number of small metabolites can 
be efficiently sampled and identified.  As an example, over 100 small metabolites have been 
measured in a single MCC neuron30 and the number of distinctive ions can further extend to 
~500 as other cells are being analyzed.  Most recently, the ion signal for each of the recorded 
ions has been monitored among various cell types, which in turn revealed characteristic 
metabolic features for different neuron types of the A. californica CNS, including B1, B2, 
MCC, PL1, R15, and R2 cells.  For example, Figure 3.2 shows that arginine and betaine are 
detected in comparable ion counts in both R2 and MCC cells.  In contrast, acetylcholine and 
serotonin are measured with a signal-to-noise ratio of >3 exclusively in the R2 and the MCC 
neuron, respectively.  Relative signal intensity ratios can also aid in differentiating among 
neuron types; the arginine/glutamic acid ratio is significantly higher for the MCC cell.  
Sub-cellular features can also be studied on a metabolic level with CE-ESI-MS.  As 
an example, the sampling step can be adjusted to isolate the soma and neurite regions of a 
giant R2 neuron.  The respective structures were placed in the extraction solution and the 
generated extract solution was analyzed by CE-ESI-MS according to the presented 
protocol.30  Figure 3.3 shows an electropherogram of the ion m/z 146.0 ± 0.5.  It is apparent 
from the traces that the two structures exhibited differing metabolite content for this 
particular m/z value. 
 
3.5.2 Metabolomics with Single-Cell MALDI MS 
Two sample preparation approaches were examined in this part of the work: on-plate cell 
deposition and in-vial analyte extraction.  Both approaches enabled the detection of a variety 
of metabolites (Figure 3.4).  More than 80 metabolite-like signals can be observed in 
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individual A. californica LP1 and R2 cells between 20 and 1000 Da.  Lower molecular 
weight species are better detected in the on-plate cell deposition strategy (Figure 3.4A, B).  In 
contrast, the in-vial analyte extraction procedure yielded higher molecular weight 
compounds, some of which could be peptides.  These differences are most likely due to the 
longer exposure time of MALDI matrix solution to the cell.  While favorable for the 
extraction of larger intracellular molecules, this would result in ion suppression of low 
molecular weight metabolite signals by the higher molecular weight compounds present in 
samples, including the peptides and proteins with an m/z above 1-1.5 kDa that were detected 
(not shown).  
PCA analysis demonstrated clear separation of data acquired by these two sample 
preparation procedures applied to these cells (Figure 3.4C).  LP1 and R2 are homologous 
cholinergic neurons; therefore, the resulting co-clustering of data points obtained from these 
neurons is not surprising.  Similar results were obtained for serotoninergic A. californica 
MCC cells (Figure 3.4D).  Extracted MCC samples (two cells, four aliquots, four technical 
replicates) are different from the on-plate treated MCC #3 cell and control DHB samples.  
MCC #1 was damaged during isolation and therefore mass spectra acquired from this cell 
were dominated by MALDI matrix signals.  As a result, these mass spectra are grouped in the 
same cluster with control DHB mass spectra.  Ion suppression due to DHB signal is lessened 
in the analyses of samples prepared on-plate; this is why the resulting data groups cluster 
along the same PC1 scale as the control DHB cluster (Figure 3.4C, D).  
Identification of detected metabolites in MALDI requires MS/MS sequencing 
because accurate m/z values are not sufficient to distinguish between isobaric compounds that 
can be present in individual cell samples.  For example, m/z 177.10 corresponds to at least 
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two compounds, such as serotonin and cotinine.  Furthermore, the sodium adduct of DHB 
has a measured m/z value of 177.12 (Figure 3.5A).  Fragmentation of m/z 177 analytes, 
performed in MS/MS mode, revealed the presence of several compounds with similar m/z 
values in the single-cell samples, DHB control sample, and serotonin standard (Figure 3.5).  
As expected, resulting mass spectra from the serotoninergic MCC cell demonstrated an 
intense fragment ion with m/z 160, which is a characteristic serotonin fragment.  This 
fragment has been detected with the CE-ESI-MS/MS approach and is listed in metabolite 
databases (see Metlin and MassBank).  This signal is also present in the MALDI mass 
spectrum of the serotonin standard (Figure 3.5B).  
 
3.6 Conclusions  
Single-cell MS is a powerful approach for the detection and identification of metabolites in a 
variety of cell types.  Assisted by a new generation of highly sensitive mass spectrometers 
and supported by the development of new methods to investigate cellular heterogeneity, 
metabolomics is becoming a mainstream discipline for bioanalytical microanalysis.  
Comprehensive experimental protocols are playing an important role in the success of 
complex, interdisciplinary projects, such as investigations of single-cell metabolomes.   
Sample preparation is a key element of single-cell analyses.  Whether investigations 
are targeted or exploratory, sample preparation steps require in-depth optimization.  Manual 
sample preparation can obviously be a bottleneck point in an analytical experiment; thus, 
advancements in automated cell isolation strategies or utilizing the aforementioned direct 
ionization techniques will enable more high-throughput sampling on the single-cell level.  
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Although a relatively recent application in the field of metabolomics, MALDI MS has 
proven advantageous for high-throughput metabolomic investigations.  The study of cell-to-
cell heterogeneity inherently requires the rapid analysis of large numbers of cells, one feature 
that is already realized by any MALDI mass spectrometer capable of adapting multi-array 
sample holders (e.g., 96-well-plates) and performing analysis in an automated fashion.  These 
instruments also offer imaging capabilities with spatial resolutions comparable to the size of 
an average single cell.  Sub-cellular resolution imaging is one direction in metabolomics that 
will likely benefit from recent developments in sample preparation approaches, including the 
stretched sample method.54  Because MALDI mass spectra are typically populated by a 
significant number of signals related to the matrix, its clusters, and impurities, automated ion 
filtering is an important requirement in advancing high-throughput investigations.    
The coupling of CE to ESI MS enables unambiguous identification of metabolites at 
the single-cell level through the combination of accurate mass, retention time, and MS/MS 
data.  While each separation can take up to an hour, the wealth of chemical information 
collected on the sample composition is impressive.  Data analysis is currently a limiting step 
in CE-ESI-MS experiments.  Software that enables automated data interpretation is highly 
desirable in metabolomics applications, especially because low detection limits allow 
measurements of hundreds of metabolites in a single cell.  This efficiency in sampling the 
metabolome opens new avenues in metabolomics.  Chemical differentiation of cell types, and 
the analysis of metabolic responses to stimuli or environmental differences, are among the 
most exciting developments enabled by CE-ESI-MS. 
While strategies for metabolite detection in single cells continue to be developed and 
refined, there are vast possibilities for their application in fundamental research and in the 
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biotechnology and medical industries.  Further investigations with established detection 
strategies, and the development of new methodologies to probe different biological systems 
on a cellular level, will help in a better understanding of the underlying biochemistry of 
phenotypic differences. 
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Table 3.1 Troubleshooting hints 
Hint # Problem Possible cause(s) Solution(s) 
1 Sparse electric sparks Electric breakdown Increase skimmer-ES emitter 
distance; lower ambient 
humidity; water- then 
methanol-rinse and dry ES 
emitter and MS skimmer 
2 Total ion chromatograms 
and/or spray currents are 
not stable 
Discontinuous solvent 
supply at emitter tip 
during ESI caused by 
bubbles in the 
electrospray solvent; 
loose connections 
Inspect electrospray solution 
in syringe for bubbles; revisit 
connections of the interface 
3 Discontinuous solvent 
supply at emitter tip upon 
CE voltage application 
Electrochemical-
induced bubble 
formation; solvent 
heating 
Sonicate and replace solutions; 
test for Joule-heating via 
current-voltage plots 
4 Irreproducible analytical 
results for quantitation 
Injection end of 
separation capillary 
lost contact with 
sample extract 
Inspect the injection step 
visually; increase the 
deposited sample volume if 
needed 
5 Analyte signal is not 
detected or is too weak 
MALDI 
matrix/detection 
polarity is not optimal 
for analyte detection 
Investigate the detection of 
analytes with different 
MALDI matrixes/detection 
polarities 
  Cell isolation 
procedure resulted in 
possible cell lysis, 
metabolites were 
released from the cell, 
or the analytes were 
metabolized 
Practice procedure for 
isolation of cells with known 
metabolites to optimize cell 
transfer manipulation; use 
pharmacological agents to 
prevent these processes prior 
to CNS dissection or protease 
treatment 
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CHAPTER 4 
 
METABOLIC DIFFERENTIATION OF NEURONAL CELL TYPES BY SINGLE-
CELL CE-ESI-MS  
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This chapter is adapted from an article submitted under “Metabolic differentiation of 
Neuronal Phenotypes by Single-Cell CE-ESI-MS with coauthors Peter Nemes, Stanislav S. 
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MS platform, ran the samples, performed principal component analysis, calculated 
concentrations of analytes within single neurons, and completed calculations of variability  
(biological and analytical).  Peter and I shared the responsibility of designing the data 
analysis workflow, acquiring intensities for the eluting analytes for input into PCA, 
minimizing the mass list for PCA, and identifying the analytes.  I also ran the standards for 
the quantitation work.  Stanislav was responsible for sample preparation, including cell 
isolation.  The authors would like to thank Xiying Wang for the single neuron preparations.  
This work was supported by the National Science Foundation (NSF) and the National 
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CHE-0400768.  
 
4.1 Introduction 
In the field of biomarker research and discovery, methods to investigate metabolic 
heterogeneity among selected cells within a cell population provide unique information on 
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cell function and fate.1-2  Cell-to-cell heterogeneity can be surprisingly broad, even for cells 
of the same type.3-4  Cell heterogeneity is also prevalent within the nervous system, with 
many different cell types present; furthermore, chemical diversity even exists between cells 
of the same type.  Metabolomic approaches are beginning to be performed on the brain to 
gain a better understanding of disease, disorders, responses to drug treatments, and functional 
roles.5-7  These findings can also complement genomic and proteomic data for complete 
characterization of these systems.  However, the majority of metabolomics assays provide 
information about average metabolite levels rather than levels in individual cells within a 
population.  While the metabolome coverage is better for tissue homogenates, if the cell 
population is heterogeneous, the chemical complexity increases when distinct cells are 
pooled before measurement.   There is currently a great, unmet demand for methodologies 
capable of investigating and quantifying the metabolome of single cells. 
Aplysia californica is a common physiological model organism that is useful for 
understanding how neurons and neural circuits control behavior.  They have relatively well-
defined neural networks within their central nervous system (CNS), with identifiable neurons 
that are responsible for physiological and functional changes.  For example, many studies 
have been accomplished with regard to learning, behavior, and memory.8-9  Furthermore, 
their CNS is relatively simple, and composed of approximately 10,000 central nerve cells10, 
while the mammalian brain consists of about 1011 neurons11, which makes it a much less 
complicated system to study.  Also, the neurons are relatively large (range of sizes), which 
enable cells, and their compartments, to be studied on multiple levels (e.g. physiological, 
biochemical, and genomic).  While studies of this system have included select metabolites 
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and genomic, proteomic, and peptidomic information, metabolomic studies have lagged and 
require further investigation. 
Mass spectrometry (MS) is an incredibly useful tool for metabolomic investigations, 
due in part to its high sensitivity and selectivity.  The number of MS-based approaches 
capable of single-cell and subcellular investigations have steadily increased,2, 12 and include 
electrospray ionization (ESI),13 secondary ion mass spectrometry (SIMS),14-16 matrix-assisted 
laser desorption/ionization (MALDI),17 nanostructure initiator mass spectrometry (NIMS),18 
laser ablation electrospray ionization (LAESI),19-20 and live video MS21.  The chemical 
complexity observed in most living systems poses challenges for broad-range molecular 
identification when applying MS alone, prompting the addition of orthogonal approaches for 
molecular characterization.   
Here, a bioanalytical approach for the metabolic analysis and classification of 
individual cells in the CNS of Aplysia californica is reported.  Label-free separation via 
capillary electrophoresis (CE) is combined with ESI MS for the detection and quantitation of 
metabolites, while integrating multivariate data analysis to identify the unique chemical 
components and patterns that distinguish cellular individuality and heterogeneity.  A number 
of different neuronal networks (and corresponding neurons) in the A. californica CNS that 
are known to play specific physiological roles are investigated: the control of the feeding 
process (metacerebral cell (MCC) and left pleural 1, (LPl1)), regulation of mucus release 
(LPl1 and R2) and gut motility (B1 and/or B2), and the mechanism of egg laying (R15).22-26  
The combined analytical approach facilitates investigations of small-volume samples, 
including the differentiation of individual neurons based on their cellular chemistry.  
Specifically, using a number of technological and methodological advancements to single-
91 
 
cell CE-ESI-MS, qualitative profiling, comprehensive identification, and quantitation for a 
number of metabolites in 50 identified and isolated A. californica neurons is achieved.  These 
advances build upon an MS-based platform recently described for volume-limited samples.13   
 
4.2 Experimental Procedure  
The sample preparation procedure (Figure 4.1) entailed the sacrifice of adult A. californica 
animals, dissection of their CNS, and isolation of select neurons.  These animals were 175–
250 g in weight, purchased from the National Resource for Aplysia (Rosenstiel School of 
Marine & Atmospheric Science, University of Miami, FL, USA), and maintained in 
continuously circulated, aerated artificial seawater cooled to 14 °C.  Eight animals were 
anesthetized by injecting 390 mM of aqueous magnesium chloride into the vascular cavity, 
equal by mass to approximately one-third of each animal’s body weight.  Ganglia and 
adjacent nerves were surgically dissected, enzymatically treated to remove connective 
tissues, and identified neurons were manually isolated in artificial seawater that consisted of 
460 mM NaCl, 10 mM KCl, 10 mM CaCl2, 22 mM MgCl2, 26 mM MgSO4, and 10 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.8, mixed with glycerol 
(v/v, 66.7%/33.3%) to stabilize the cell membrane.  The isolated cells included the MCC, 
LPl1, R2, B1, B2, and R15 neurons.  Cells were quickly rinsed with deionized water to 
minimize inorganic salt and extracellular metabolites on their surfaces.  Finally, isolated 
neurons were placed into 50% (v/v) methanol solution prepared with 0.5% (v/v) acetic acid 
to facilitate analyte extraction and quenching of enzymatic processes ex vivo.  The samples 
were stored in the solution at –20 °C until analysis.  Control experiments confirmed that this 
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environment minimized metabolite decomposition for periods as long as two weeks and also 
facilitated analyte extraction into the solution (data not shown).   
A schematic of the instrument platform is shown in Figure 4.2.  A multi-channel data 
acquisition and control card (model USB-6008, National Instruments, Austin, TX, USA) was 
operated by a personal computer that executed a custom-written program (LabVIEW 8.2 
interface, National Instruments); the card was programmed to generate a time-dependent 
voltage function.  The voltage was ramped over a period of 10 s from 0 kV to 20 kV and 
maintained at this voltage during the separation.  A 10 kΩ resistor was connected in series 
into the electrophoretic circuit to monitor the CE capillary current.   
The instrument platform also featured a co-axial sheath-flow arrangement similar to 
that described in earlier work.13  In the present study, a microtee assembly (part P-875, IDEX 
Health & Science, Corp., Oak Harbor, WA, USA) housed a stainless steel emitter (130 µm 
ID, 260 µm OD, part 21031A, Hamilton Company, Reno, NV, USA).  The distal end of the 
metal emitter was cleaved and finely polished to provide a well-defined anchoring rim for the 
electrified liquid meniscus.  For separation, a fused silica capillary (FSC in Figure 4.2) with 
an internal diameter (ID) of 40 µm and an outer diameter (OD) of 110 µm (Polymicro 
Technologies, Phoenix, AZ, USA) was used.  Both ends of the capillary were cleaned and the 
polyimide coating thermally removed.  The fused silica capillary was coaxially fed through 
the emitter and protruded ~50–80 µm into the Taylor-cone.   
The sheath liquid (50% methanol with 0.1% formic acid) was supplied through the 
emitter at a 750 nL/min flow rate using a syringe pump (model 70-2000 or 55-2222, Harvard 
Apparatus, Holliston, MA, USA) and a fused silica capillary for the delivery of the sheath 
flow (S in Figure 4.2) (75 µm ID, 363 µm OD, Polymicro Technologies).  The emitter was 
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grounded and initially positioned ~20 mm in front of the skimmer plate of the mass 
spectrometer.  The potential on this plate was adjusted to –1700 V using the software of the 
mass spectrometer, and the emitter-plate distance was cautiously decreased until cone-jet 
spraying mode was achieved.   
The cell extract solutions were centrifuged for 1 min at 2000 × g, and 500 nL aliquots 
were deposited into a stainless steel sample loading vial (SV in Figure 4.2).  The injection 
end of the fused silica capillary was positioned into the sample loading vial and elevated 15 
cm with respect to the outlet end for 60 s.  The hydrostatic pressure generated across the 
capillary allowed the reproducible introduction of 6 nL of the deposited sample solution into 
the separation capillary (equivalent to ~0.1% of the total cell content).  Following this step, 
the sample loading vial was lowered to 3 cm above level with the outlet end, and the inlet 
end of the capillary was positioned into a stainless steel vial containing 1% formic acid as the 
background electrolyte (BV in Figure 4.2).  A 20 kV separation potential was applied.   
Generated ions were analyzed by a micrOTOF ESI-time-of-flight (TOF) mass 
spectrometer or a maXis ESI-Qq-TOF-MS/MS mass spectrometer (Bruker Daltonics, 
Billerica, MA, USA) with ~5 ppm mass accuracy and ~8000 FHWM (full width at half 
maximum) resolution.  These instruments were run in positive ion mode.  MS/MS 
experiments with 20–35 eV collision energies facilitated the molecular identifications.  The 
analytical reproducibility of the CE-ESI-MS setup was also tested with a chemical standard 
solution containing acetylcholine, dopamine, and histamine, each at a 50 nM concentration.   
The acquired electropherograms were initially surveyed by generating m/z-selected 
ion chromatograms in the 50–500 m/z-range with a step size of 500 mDa.  After determining 
the eluting species from the identified neurons, the total analyte list was minimized to 140 
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analytes that would be monitored for the identified neurons (Table 4.1).  This list was 
generated by removing interfering chemical species, adducts, and ions with intensities less 
than 5 × 105 counts.  Selected ion-electropherograms were generated for each of these ions 
with a ± 50 mDa mass window and the corresponding electrophoretic peak maxima was 
determined for subsequent principal component analysis (PCA).  Chemometric data 
interpretation and quantitation were performed on signal intensities of eluting species with 
unsupervised PCA (Markerview 1.1; Applied Biosystems, Carlsbad, CA, USA).  Data 
preprocessing weighting and scaling was logarithmic and mean center, respectively.  All data 
were plotted by a scientific visualization software package (Origin 8.0; Northampton, MA, 
USA).   
  
4.3 Results and Discussion 
The CE separation step reduced the chemical complexity of the neuron samples prior to MS 
detection, enabling the simultaneous measurement of a vast number of intracellular 
compounds.   A survey of the detected ions indicated the presence of at least 300 different 
molecular species within a single neuron in some cases.  Many of them were identified using 
accurate mass measurements combined with online metabolite database searches, as well as 
collision-induced dissociation tandem MS (MS/MS) data and migration-time comparisons 
against chemical standards.  Thirty-six ions were ascribed with high analytical confidence to 
small metabolites, osmolytes, and classic neurotransmitters (Table 4.2).   
A total of 140 ionic species were then selected from the remaining ion list for further 
analysis and are tabulated in Table 4.1.  This evaluation revealed signals for over ~450 
different accurate mass-to-charge ratios, each corresponding to a different ionic species.  
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Careful control experiments were conducted to analytically evaluate the cellular and 
analytical environments.  A number of interfering chemical species were found and ascribed 
to polymer and plasticizer molecules, likely originating from solvent bottles, impurities 
present in the solutions used (methanol, water, and formic acid), as well as noncovalent 
adducts that formed in situ during electrospray ionization.   
Measurements performed on the standard solution on four consecutive days revealed 
an analytical reproducibility of 12 ± 2 relative %.  Likewise, the biological reproducibility 
was assessed by monitoring 144 different ion signal intensities for different neuron extracts, 
as follows: B1 (10), B2 (8), MCC (9), LPl1 (6), R15 (8), and R2 (8).  Relative standard 
deviations were calculated for each ion signal as a function of neuron type and are 
summarized in Figure 4.3.  The histograms show that the distribution of the relative error was 
normal for most cell types and had a median of ~25–50 relative % for the majority of the cell 
types, except for the B2 neurons that occasionally reached 100%.  Because the analytical 
reproducibility of the CE-ESI-MS setup was below 20 relative %, these higher error levels 
observed for the neuron types were ascribed to the biological variability among the animals 
and their phsyiological states.   
Analysis of selected-ion electropherograms revealed the neuron-specific presence of a 
number of ions.  Representative examples are shown for the MCC, LPl1, R15, and R2 neuron 
extracts in Figure 4.4.  Acetylcholine (compound 9, see also Table 4.2) registered in high ion 
counts in both the R2 and LPl1 neurons.  In contrast, serotonin (13) was only measured in the 
MCC cells, an observation confirmed by independent studies reporting that MCC neurons 
use serotonin as a neurotransmitter.27-28  Similarly, the ion m/z 267.1333 (unknown identity, 
UN) was exclusively found in the R15 neurons.  This unknown mass matches the formula 
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C13H18N2O4 within 1 ppm accuracy, and may correspond to the dipeptide ThrPhe (or 
PheThr); future work will validate the assignment of this cell-specific metabolite.  In Figure 
4.4, the registered mass-to-charge ratio (m/z)-selected electropherograms were temporally 
aligned by using retention times for the HEPES buffering agent and endogenous lysine, 
tryptophan, and glutathione for nonlinear multi-parameter regression.   
Other compounds populated the cell extracts in fairly uniform ion counts.  Glycine 
betaine (32) was generally detected in high abundance in most of the interrogated cells 
(Figure 4.4).  In agreement with this observation, glycine betaine is a well-known 
intracellular osmolyte and is present at 100–300 mM in the intracellular space.29  These 
results impart confidence that the CE-ESI-MS platform not only measured endogenous 
metabolites from neuron extracts, but also yielded data that represents the biological 
composition of the neurons.   
The results provided an opportunity to investigate the cellular heterogeneity and 
classify individual neurons at a chemical level.  PCA was employed to further distinguish the 
cell types.  Seven to nine individual neurons (biological replicates) were isolated from 
different A. californica animals and were analyzed in duplicate (technical replicate) for each 
of the following neuron types: B1, B2, MCC, LPl1, R2, and R15.  Using PCA on 144 
different selected ions (Table 4.1), the vast datasets yielded in these experiments (over 
~14,000 ion intensity values) were mathematically transformed into orthogonal components 
to reduce data dimensionality, helping to reveal underlying chemical correlations among the 
studied neurons. 
PCA of the CE-ESI-MS data demonstrated that the neurons exhibited individual as 
well as cell type differences in their chemistry. The first two principal components (Figure 
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4.5) explained ~70% of the total variance among the measured ion intensities. The biological 
variability (~25–50%., Figure 4.3), exceeded the analytical reproducibility (below 20%); 
thus, only single measurements are included in Figure 4.5 to aid in visual data interpretation.  
Notably, data points from the LPl1 and R2 neuron extracts form overlapping clusters in the 
first two orthogonal dimensions.  Likewise, most B1 and B2 single cells are virtually 
indistinguishable in Figure 4.5.  These PCA results demonstrate that these neuron pairs 
possess similar chemical compositions.  In contrast, the MCC and R15 data clusters 
populated in distant quadrants of the scores plot, indicating significantly different metabolic 
profiles for these neurons as compared to the other four cell types.  
The chemical observations add an important piece of evidence to the existing 
physiological differences of neuronal cell type.  Previously, the evidence that these cells were 
homologous included morphological observations on the almost symmetrical axonal trees 
over the body walls of the animal, and that both neurons are cholinergic.24, 30  The PCA 
results confirmed that, even though located in nonsymmetrical ganglia, the LPl1 and R2 
neurons were biochemically homologous.   
Chemical heterogeneity was observed for single neurons within the same neuronal 
type.   As shown in Figure 4.3, the R2 and LPl1 neurons arranged into tight data clusters 
(small cluster radius) whereas the variance appeared to increase in the following order: R15, 
LPl1 < MCC < B2 << B1.  Moreover, three of the B1 and one of the B2 neurons had 
significantly different chemistry than the others.  Because cell isolations and chemical 
analyses were performed with sufficient confidence, the observed cellular heterogeneity may 
be explained by biological variation among animals and their specific chemical and 
biological state.   
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Metabolites correlating with the observed chemical relationships among cells and cell 
types were screened using PCA.  The loading plot in Figure 4.5 helps to distinguish the ions 
that made the highest contribution in differentiating the studied neurons.  For example, the 
histamine (1) and serotonin (13) ions occupy the left lower quadrant of the plot.  These ions 
are specific to MCC neurons.  In contrast, acetylcholine (9) has the highest PC2 value in the 
top right region in Figure 4.5.  This piece of information allows for the screening of 
cholinergic cells.  Notably, glycine betaine (32) and proline betaine (33) are in close vicinity 
to the origin, which indicates low specificity for any of the studied neurons.  It is in 
accordance that both these compounds are intracellular osmolytes and are found in usually 
high abundance in some marine animals, including sea slugs.29, 31   
This bioanalytical platform also enables the quantitation of metabolites detected in 
the neurons.  Following external calibration, the serine and glutamic acid levels were 
measured in the following six different neurons: B1, LPl1, R2, and R15 (Figure 4.6).  In 
excellent agreement with independent results,32-33 the intracellular glutamic acid 
concentration was measured to be ~11.4 mM in the R2.  The glutamic acid levels were found 
to be lowest in the B1 and highest in the LPl1 extracts on average (Figure 4.6), with the 
intracellular concentration difference reaching one order of magnitude (Table 4.3).  In 
contrast, the serine amounts did not appear to significantly change with cell type but rather, 
with neuron individuality.  For example, the concentration difference was almost a 
magnitude greater between the B1 neurons a and c (Table 4.3).  These results further stress 
the importance of quantitatively assessing cell chemistry with single-cell resolution.   
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4.4 Conclusions and Future Work 
Label-free analysis, metabolite quantitation, and chemical screening are demonstrated for 
isolated identified single cells from the CNS of one of the most investigated neurobiological 
models, A. californica.  A total of 50 individual identified neurons, including B1, B2, MCC, 
LPl1, R2, and R15, from eight animals were classified on a biochemical level.  Furthermore, 
this analysis strategy could also be implemented to determine the effects of chemical or 
electrical stimuli for different cell types to gain further information about the chemical 
cellular response.   
It is worthwhile noting that the signal filtering criterion did not bias among chemical 
classes (e.g., osmolyte versus neurotransmitter molecules), but exhibited preference for 
signal intensity.  Data analysis is commonly the most time consuming part of metabolomic 
analyses; developments in automation and computer processing can help simultaneously 
monitor the ~300 metabolites detected in future experiments.  Nevertheless, 144 of these ions 
were targeted here, and the obtained results demonstrate the broad applicability of the single-
cell analytical platform and methodology.  Future work will involve identifying additional 
analytes that contribute to cell differentiation, such as those shown in the loadings plot in 
Figure 4.5. 
Although single cell isolation presents a bottleneck in the current experiment 
workflow, enhancements in cell sampling have the potential to significantly increase 
analytical throughput.  The combination of continuous cell delivery and lysis with 
microfluidic devices poses an elegant solution, and this approach has recently demonstrated 
protein analysis, feasible with sampling rates as high as 12 cells a minute.34  Furthermore, 
microfabrication and micropatterning opens an opportunity to mimic the cell environment, 
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allow the separation of spatial and temporal factors in cell regulation, and apply rapid 
nutrient gradients.  These innovations can also help to unravel the parameter space of 
experimental conditions to facilitate the design of extended cell studies.  The analysis of 
large numbers of single cells in turn will yield statistically sound data to represent the 
biochemistry of a given cell population. 
Advances in software frameworks for mass spectral data exploration are expected to 
greatly complement research efforts in metabolomics, including the present single-cell 
analysis approach.  CE-ESI-MS of the neurons studied in this work generated ~200 GB 
electropherogram data in single-stage MS mode.  The interpretation of this large amount of 
information demands physical computing power, as well as the availability of sophisticated 
software platforms.  In addition, manual data analysis revealed that the CE-ESI-MS platform 
registered molecular features over a broad range of peak widths (ranging from 5 s to ~60 s); 
this in combination with occasional low migration time reproducibility among analyses 
challenged molecular feature detection using commercial software packages. 
Sophisticated mathematical algorithms such as the open-source XCMS35, MZmine36, 
MathDAMP37, and most recently metaXCMS38 data-analysis tool-boxes are promising means 
to aid the analytical workflow. Reduction in the data set size, exploration of spectral features 
with high temporal resolution, and the feasibility of direct statistical analysis on non-targeted 
datasets are apparent advantages of similar software venues for metabolomics. Once spectral 
features are identified, ideally these software platforms would allow the direct screening of 
on-line high mass-resolution MS(-MS) metabolite depositories such as the Metlin39 database 
for automated metabolite identification. 
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The interrogation of cell individuality and cell type by the herein described approach 
adds chemical insight to cellular bioanalyses.  It is expected that single-cell studies on the 
mammalian CNS will show similar and striking cell to cell heterogeneity.  Enhancements in 
cell sampling, perhaps via microfluidic devices, will further increase analytical throughput.  
These protocols and techniques are readily adaptable from cells to other volume-limited 
samples requiring the detection and quantitation of nanoliter volumes of metabolites.   
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Table 4.1 Ions monitored for principle component analyses.  These 144 ions were selected 
from over 300 distinctive ionic species detected from among single neurons analyzed by CE-
ESI-MS.  Ions highlighted in grey and bold were ascribed to specific metabolite molecules 
and are listed in Table 4.2. 
76.04 90.05 90.06 90.06 94.05 104.07 104.07 104.07 104.07 104.11 106.05 112.09 
116.07 118.09 118.09 118.12 120.07 120.07 122.08 122.08 123.06 126.02 128.01 130.09 
132.10 132.10 132.10 132.10 133.10 134.05 134.08 144.10 144.10 146.12 146.12 146.12 
147.08 147.11 148.06 150.11 150.11 151.61 156.08 160.10 161.09 161.12 162.08 162.08 
162.08 162.11 164.07 165.10 166.09 170.09 175.11 175.11 175.12 177.10 179.05 180.10 
187.05 188.07 189.12 189.12 189.12 189.13 189.15 191.07 193.07 193.09 196.10 203.14 
182.08 203.14 203.14 204.12 204.13 205.10 205.12 209.09 217.16 218.14 218.15 218.15 
218.15 221.10 221.12 223.08 231.17 232.13 232.14 232.16 233.11 233.15 233.15 234.15 
235.11 237.12 237.12 239.11 242.56 242.63 244.09 245.18 245.19 246.14 246.16 246.16 
248.09 248.16 248.16 248.16 249.12 253.12 254.07 255.10 260.16 260.16 260.16 260.20 
260.20 260.20 261.14 263.12 263.14 265.11 265.12 267.13 267.13 267.14 268.10 273.12 
274.18 274.19 274.21 275.16 284.10 288.20 291.13 301.11 308.09 322.11   
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Table 4.2 Metabolites identified from single neurons of the A. californica CNS.    All 
accurate masses were calculated with Molecular Weight Calculator, version 6.46 (available 
from http://ncrr.pnl.gov/software/). Key: migration time, tm; absolute and relative mass 
accuracy, ; MS/MS confirmed, *. 
Identifier Name Formula
1 histamine C5H9N3 8.6 112.0875 112.0875 -0.1 -0.89
2 thiamine C12H17N4OS 12.2 265.1115 265.1123 0.4 3.84
3 choline C5H14NO 13.1 104.1078 104.1075 0.8 3.02
4 ornithine* C5H12N2O2 14.1 133.0983 133.0977 -0.6 4.51
5 lysine* C6H14N2O2 14.2 147.1136 147.1133 -0.6 -4.51
6 β-alanine C3H7NO2 14.3 90.0558 90.0555 -0.3 -2.04
7 nicotinamide C6H6N2O 14.6 123.0588 123.0558 -0.3 -3.33
8 arginine* C6H14N4O2 14.8 175.1191 175.1195 0.4 2.28
9 acetylcholine* C7H16NO2 14.8 146.118 146.1181 0.1 0.68
10 -aminobutyric acid C4H9NO2 15.0 104.071 104.0711 0.1 0.96
11 histidine* C6H9N3O2 15.1 156.0775 156.0773 -0.2 -1.28
12 carnitine* C7H15NO3 17.2 162.1129 162.113 0.1 0.62
13 serotonin C10H12N2O 17.5 177.102 177.1028 0.8 4.52
14 acetylcarnitine* C9H17NO4 18.7 204.1233 204.1236 0.3 1.47
15 glycine C2H5NO2 19.4 76.04 76.0399 -0.1 -1.32
16 cytidine C9H13N3O5 20.1 244.093 244.0933 0.3 1.23
17 adenosine* C10H13N5O4 20.7 268.1045 268.1046 0.1 0.37
18 alanine C3H7NO2 21.5 90.0553 90.0555 0.2 2.22
19 valine* C5H11NO2 24.9 118.0864 118.0868 0.4 3.39
20 isoleucine* C6H13NO2 25.3 132.1026 132.1024 -0.2 -1.51
21 serine C3H7NO3 25.5 106.0506 106.0504 -0.2 -1.89
22 leucine* C6H13NO2 25.6 132.1025 132.1024 -0.1 -0.76
23 threonine C4H9NO3 27.3 120.0657 120.0661 0.4 3.33
24 indoleacrylic acid* C11H9NO2 27.8 188.071 188.0711 0.1 0.53
25 tryptophan C11H12N2O2 27.8 205.0974 205.0977 0.3 1.46
26 glutamine* C5H10N2O3 28.1 147.0768 147.077 -0.2 -1.36
27 glutamic acid* C5H9NO4 28.7 148.0611 148.061 -0.1 -0.68
28 phenylalanine* C9H11NO2 29.1 166.0871 166.0868 -0.3 -1.81
29 tyrosine* C9H11NO3 29.6 182.0814 182.0817 0.3 1.65
30 proline* C5H9NO2 30.1 116.0714 116.0711 -0.3 -2.58
31 aspartic acid* C4H7NO4 32.7 134.0454 134.0453 -0.1 -0.75
32 glycine betaine C5H11NO2 32.8 118.0872 118.0868 -0.4 -3.39
33 proline betaine* C7H13NO2 33.6 144.1021 144.1024 0.3 2.08
34 β-alanine betaine C6H13NO2 37.0 132.1026 132.1024 -0.2 -1.51
35 glutathione C10H17N3O6S 37.9 308.0913 308.0916 0.3 0.97
36 taurine C2H7NO3S 50.2 126.0226 126.0225 -0.1 -0.79
Δ (ppm)
Compound
t m (min)
m/z 
measured
m/z 
theoretical Δ (mDa)
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Table 4.3 Representative examples for glutamic acid and serine concentrations measured in 
identified isolated neurons from the A. californica CNS.  Concentrations are given for [a] the 
extract solution and [b] cellular concentration assuming a homogeneous distribution and an 
average cell diameter of 100 µm for the B1 neurons, 200 µm for the R15 neurons, and 300 
µm for the LPl1 and R2 neurons.  Calibration curves for ion intensity, I (counts), and 
concentration, c (µM), from linear fittings in Figure 4.6 were log(I) = 11.75 + 0.88 log(c) for 
glutamic acid (R2 = 0.998) and log(I) = 12.49 + 1.07 log(c) for serine (R2 = 0.997).  The 
relative standard deviation for quantitation was below 20%.   
 
Glutamic acid Serine
Identifier Type (µM)[a] / (mM)[b] (µM)[a] / (mM)[b]
a B1 1.7 / 0.6 1.5 / 0.5
b B1 2.0 / 0.7 0.5 / 0.2
c B1 3.5 / 1.2 5.1 / 1.8
d B1 4.6 / 1.6 12.6 / 4.5
e LPl1 34.0 / 12.0 6.9 / 2.5
f LPl1 36.1 / 12.8 7.8 / 2.7
g LPl1 36.9 / 13.1 9.6 / 3.4
h LPl1 39.4 / 13.9 8.7 / 3.1
i R2 23.7 / 8.4 6.5 / 2.3
j R2 33.5 / 11.8 6.8 / 2.4
k R2 30.6 / 10.8 4.1 / 1.4
l R2 40.9 / 14.5 6.9 / 2.4
m R15 8.5 / 10.1 1.4 / 1.7
n R15 9.9 / 11.9 2.2 / 2.6
o R15 18.0 / 21.5 3.5 / 4.2
p R15 22.9 / 27.3 5.3 / 6.4
Neuron
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CHAPTER 5 
 
A LACK OF MAST CELLS CAUSES STRIKING METABOLITE DEFECTS IN THE 
HIPPOCAMPUS 
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5.1 Introduction  
Mast cells are hematopoietic cells that are involved in immune and allergic responses.  These 
cells have large granules containing a number of chemical mediators, such as histamine, 
serotonin, and cytokines, which can be generated and released upon activation.1-2  Mast cells 
are located both in the periphery and the brain, but their involvement and role in the brain is 
less clear.  For example, it has been demonstrated that mast cells can migrate from blood to 
the brain3 and that mast cells numbers increase in the central nervous system (CNS) 
following stress4.  Furthermore, a lack of mast cells has been shown to cause anxiety-like 
behavior.5  It has also been demonstrated that mast cells influence memory, spatial learning, 
and neurogenesis, despite their relatively small numbers in the hippocampus.6 
Given the interesting, emerging roles that mast cells contribute to behavior and 
development, chemical influences of this cell type to the brain would provide additional 
insight into mast cell involvement.  In this study, mast cell-deficient W-sash (Wsh/Wsh) mice 
are used to determine metabolites that mast cells contribute to the hippocampus and their 
involvement in metabolic pathways.  These mice carry a naturally occurring mutation in the 
white spotting locus (W), which causes reduced c-kit receptor expression.7  Mast cell 
proliferation, differentiation, survival, and regulation are dependent upon this expression.8  
Therefore, this mutation results in abnormalities in an inability for mast cells to differentiate 
from their myeloid progenitors, which provides an excellent model for studying mast cell 
biology.9-10  Wsh/Wsh mice have been shown to have no abnormalities in any other 
hematopoietic cell lineage, although they do exhibit abnormalities in pigmentation.11-12   
Metabolomics investigations characterize the small molecule content of a given 
sample and are often useful in revealing differences between sample types or physiological 
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states, especially with regard to disease.13-15  These approaches have been useful in a variety 
of applications, such as determining molecular differences in brain tumors16 to characterizing 
the molecular composition of single neurons.17-18  Transcriptomic analyses have also been 
indispensible in brain research; for example, gene expression was characterized in different 
cell types in the brain, including neurons, astrocytes, and oligodendrocytes, where 
oligodendrocytes and astrocytes were found to be as dissimilar as they are to neurons, despite 
both being considered glia.19  Given that prior work has shown that a mast cell deficit has 
profound effects on animal behavior and neurogenesis within the hippocampus,5-6 the 
chemistry of this system is investigated to understand how relatively few cells, located within 
and surrounding the hippocampus, yields such a result.  Taking a systems biology approach, 
metabolism and cell-to-cell signaling information is combined with transcriptomic data to 
determine the chemical contributions that mast cells make to the hippocampus.  Metabolite 
profiling is achieved with capillary electrophoresis (CE) coupled to electrospray mass 
spectrometry (ESI MS) for metabolite detection and identification  and transcriptomic data is 
collected using microarrays to determine differentially expressed genes.  The combination of 
this data reveals that mast cells alter a surprising range of metabolites and are implicated in a 
number of critical pathways.  
 
5.2 Experimental Procedure  
5.2.1 Chemicals 
The chemicals and reagents used were from Sigma-Aldrich (St. Louis, MO) unless indicated 
otherwise: 1xHBSS without phenol red (Invitrogen, Carlsbad, CA), Water (LC-MS grade 
Chromosolv®), methanol (Optima®, Fisher Scientific, Fair Lawn, NJ), formic acid (FA) 
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(99+%, Thermo Scientific, Rockford, IL), acetic acid (99+%), 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) (99.5%), RNAlater-ICE (Applied Biosystems, 
Austin, TX) 
 
5.2.2 Animals 
All animal care and testing were approved by the Columbia University Institutional Animal 
Care and Use Committee.  Mast cell-deficient mice (Wsh/Wsh) were originally obtained from 
Jackson Laboratories and a colony was established at the Columbia University animal 
facility.  The Wsh/Wsh mice were crossed with wild-type C57BL/6 mice, to generate 
heterozygous mice (Wsh/+), which have brain mast cells.  Male mice from Wsh/+ x Wsh/+ 
crosses were used in these experiments and were also used to obtain homozygous mice with 
mast cells (+/+).  Additionally, wild-type mice, WT, (C57BL/6, Charles River) were used for 
the gene expression analysis.  Litters were weaned at 28 days and mice were housed 2-5/cage 
in transparent plastic bins (36×20×20 cm) in a 12:12 light-dark cycle.  Cages had corn cob 
bedding (Bed-o’cobs, Maumee, OH) and food and water were provided ad libitum.  For the 
CE-ESI-MS analysis, animals were sacrificed by rapid decapitation and the brains were 
removed from the crania and placed in ice cold HBSS.  Mice used in the gene array studies 
were sacrificed by decapitation and brains were rapidly removed from crania, flash frozen in 
liquid nitrogen, and then transferred to a cryostat kept at -20 °C.   Coronal brain sections 
were cut at 50 μm and the right hippocampus was dissected out of three adjacent sections and 
pooled together in 0.5 mL of RNAlater-ICE pre-cooled to -20 °C.  Following 24 h at -20 °C, 
RNAlater-ICE was removed and the tissue sample was frozen at -80 °C until processing.  
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5.2.3 Sample Preparation for CE-ESI-MS  
Brain slices were cut on a vibratome in ice cold HBSS, where the left caudal hippocampus 
was dissected.  Extraction solution (50/50 methanol/water with 0.5% (v/v) acetic acid) was 
applied for a concentration of 20 µL/mg of tissue.  The tissue was grossly homogenized and 
was extracted for 90 min at 4 °C.  The sample was centrifuged at 15,000 g for 15 min and the 
supernatants were transferred to polymerase chain reaction (PCR) tubes to better 
accommodate the sample volume; the samples were frozen at -80 °C until analysis.  An 
internal standard, HEPES, was added to the sample extracts for a final concentration of 1 
µM.  The number of biological replicates is as follows: Wsh/Wsh(10), Wsh/+(9), +/+(5). 
 
5.2.4 Allergy Induction 
For the gene microarray study, Wsh/+ and Wsh/Wsh littermates were subjected to allergy or 
saline control treatment.  Induction of mast cell-dependent allergy was performed as 
previously described.20  Briefly, mice were injected with ovalbumin (10 μg; Sigma Aldrich, 
St. Louis, MO) in Imject Alum (2 mg/mL; Pierce, Rockford, IL) or an equivalent volume of 
saline (0.5 mL) via intraperitoneal injection.  Fourteen days later, mice were challenged 4 
times, every 48h, with an intranasal injection of ovalbumin (10 μL in 8 μL of saline) or saline 
(8 μL).  Twenty-four hours following the last intranasal injection, mice were sacrificed.  
Trunk blood was also collected at this time for measure of serum IgE to confirm allergy 
induction, which was not different between genotypes in saline or allergy conditions (data 
not shown).  
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5.2.5 CE-ESI-MS 
The instrument platform is similar to what was used previously18 and has been described in 
detail elsewhere.21-22  Briefly, a coaxial sheath flow interface was used to hyphenate the CE 
and MS.  The CE conditions used were 20 kV for the separation voltage, 6 nL injection 
volumes via hydrodynamic injection, 1% formic acid for the background electrolyte, and 
50/50 methanol/water with 0.1% (v/v) formic acid for the sheath flow introduced at a rate of 
750 nL/min.  The CE capillary (Polymicro Technologies, Phoenix, AZ) was 90 cm in length 
with a 40 µm inner diameter and 105 µm outer diameter.  Single-stage experiments were 
performed using the micrOTOF ESI-TOF-MS (Bruker Daltonics) and tandem MS (MS/MS) 
experiments used the maXis ESI-Qq-TOF-MS/MS (Bruker Daltonics).  Three technical 
replicates were run for each sample. 
 
5.2.6 CE-ESI-MS Data Analysis 
Data processing was performed using the instrument software from Bruker Daltonics 
(DataAnalysis).  Initial data mining was done to determine the molecular content of the 
mouse hippocampus.  Extracted ion chromatograms, from m/z 50 to 500 were plotted at a 
+0.5 Da window.  When an eluting peak was observed, the accurate mass of the ion was 
obtained to create an analyte list (Table 5.1).  Initial analyte assignments were performed 
using Metlin, the Scripps metabolite database.23  Accurate mass calculations were performed 
using a molecular weight calculator, which is free, downloadable software through Pacific 
Northwest National Laboratory.  The tandem MS (MS/MS) data obtained from the sample 
was compared against fragmentation data listed in Metlin when available.  Standards were 
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also analyzed for additional analyte identification using MS/MS data and retention time 
order. 
After analytes were identified, ion electropherograms were generated at a 0.01 Da 
window and the peaks were integrated to obtain the peak intensity.  The list of monitored 
ions is listed in Table 5.1.  In some cases, the concentration of analyte was large enough to 
cause potential saturation of the detector; several analytes were also monitored for the second 
peak in the isotopic series, since the isotopic ratios remain constant.  Intensities were 
normalized with respect to the peak intensity of the internal standard, HEPES.  Respective 
intensities from the technical replicates were averaged to obtain representative peak 
intensities for each individual analyte.  The p-values were determined using a two-tailed 
distribution with two-sample equal variance (homoscedastic) in Microsoft Excel.   
 
5.2.7 Gene Array  
Total RNA was isolated using RNAqueous Micro RNA (Ambion) isolation kits. RNA was 
quantified with Quant-IT RNA fluorometric assay (Invitrogen) and checked for integrity 
using an Agilent Bioanalyzer. The resulting RNA samples were amplified using a 
conventional IVT linear amplification procedure (MessageAmp, Ambion), reciprocally 
labeled with AlexaFluor 546 or AlexaFluor 647 for induced allergy and control samples, and 
hybridized to whole-genome gene expression arrays (SurePrint G3 Mouse GE 8x60K Kit, 
Agilent). The resulting raw signal intensity data was filtered for background and technical 
outliers, normalized for dye and array effects, and compared for differential gene expression 
using hypothesis testing statistics similar to those previously described24-25 using appropriate 
statistical packages and subroutines implemented in R and Bioconductor26.  Differentially 
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expressed genes between the groups were selected at < 0.5% FDR (typically 1 to 3 expected 
false-positives per set) and more than two-fold change in expression.  PCA analysis of all the 
profiles shows separation between allergic and control groups (data not shown).  Differences 
in genes of interest related to the CE-MS data were pulled out of the dataset, with specific 
focus on genes in choline and autophagy pathways.   
 
5.3 Results  
The hippocampi from mast cell-deficient mice (Wsh/Wsh) were compared against hippocampi 
from their heterozygous (Wsh/+) and homozygous littermates (+/+) to determine molecular 
contributions from mast cells.  Extracts from these tissues were monitored and characterized 
for metabolite content using CE-ESI-MS.  The relative levels of individual metabolites were 
obtained to determine if any statistical molecular differences were present.  Transcriptome 
data was collected via total RNA isolation followed by hybridization to whole-genome gene 
expression arrays to compare gene expression differences in the hippocampus between wild-
type mice (WT) and mast cell-deficient mice (Wsh/Wsh), which are saline- and allergy-treated.  
The allergy treatment allows additional information regarding mast cells to be gained due to 
their integral involvement in allergic response.  The results of these combined molecular 
investigations are detailed below.  Additionally, mast cell numbers were counted in the right 
hemisphere in every other section of the hippocampus; this is shown in Figure 5.1.  The 
intracranial locations of mast cells in mice have been documented previously.6 
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5.3.1 Metabolomics 
In this work, 42 analytes were monitored in hippocampi from Wsh/Wsh, Wsh/+, and +/+ mice, 
which are shown in Table 5.1.  The majority of eluting ions were identified by a combination 
of accurate mass, retention time, and tandem MS (MS/MS) fragmentation; the ions are listed 
in order of increasing mass.  Fragmentation data was confirmed either by running a standard 
for the putative compound or comparing it to published fragmentation data in metabolite 
databases, such as Metlin.23 
 Out of these 42 analytes, 11 analytes displayed statistically significant differences (p-
value < 0.05) between the Wsh/Wsh and Wsh/+ mice.  Included in these differences are amino 
acids, choline, nicotinamide, hypoxanthine, and carnosine, as shown in Figure 5.2.  It is 
curious that among these differences, Wsh/Wsh mice all have relatively lower analyte levels 
when compared to their heterozygous littermates.  The +/+ mice were also analyzed to 
determine if similar trends were present when comparing against these different genotypes.  
It was observed that statistical differences between the Wsh/Wsh and +/+ mice were also 
present, but in varying degrees.  These additional differences are shown in Table 5.2 and 
include creatinine, betaine, acetylcholine, and glutathione, and a few additional amino acids.  
Furthermore, it was observed that there are graded effects for a number of analytes, despite 
these analytes not exhibiting statistical significance (Wsh/Wsh < Wsh/+ <+/+). 
 
5.3.2 Transcriptomics 
The hippocampi from Wsh/Wsh mice were compared to that of Wsh/+ and WT mice to 
determine differences in gene expression.  Because mast cells are intimately involved in 
allergic response, gene expression data was also collected for mice exposed to either allergy 
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or saline.  Several gene expression differences, that are related to the observed metabolite 
changes, were detected between both allergy-treated versus saline-treated mice and between 
Wsh/Wsh and Wsh/+ mice; these differences are displayed in Table 5.3.  Among these observed 
differences are acetylcholinesterase, pyruvate dehydrogenase (lipoamide) beta (Pdhb), and 
genes involved in autophagy.   
Because the differentially expressed genes appeared to be related to the observed 
changes in metabolites, the data was further examined to determine relationships between the 
gene expression and metabolite data.   First, a list of involved metabolic pathways was 
generated for metabolites. A similar list was generated for differentially expressed genes.  
Here, differences were examined between WT mice that were allergy- and saline-treated; 
similarly, allergy- and saline-differences were determined for Wsh/Wsh mice.  Then, attention 
was focused on genes where saline- and allergy-exposed differences were observed in the 
Wsh/Wsh mice, but not in the WT mice to generate a list of genes that are specifically 
associated with mast cell response.  Both the metabolite and differentially expressed gene 
lists appeared to share many of the same pathways.  A list of shared pathways was then 
generated and put into a graphical format through hierarchal clustering analysis; this is 
shown in Figure 5.3.  In the figure, a yellow block corresponds to a match between a 
metabolite and a corresponding affected pathway found through the differentially expressed 
gene analysis.  It was observed that the majority of affected pathways and metabolites are 
connected, forming a single network, despite the use of different control mice (WT and +/+).      
 
5.4 Discussion 
Metabolite differences are observed between Wsh/Wsh and Wsh/+ mice, which can be 
explained by information in the literature and through combining metabolomic and 
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transcriptomic approaches.  Given the relatively few mast cells that are present in and 
surrounding the hippocampus, it is surprising that the chemistry of the hippocampus would 
be affected to this degree.  The relationship between observed metabolite differences and 
differential gene expression is described.  Finally, specific molecular changes are addressed 
that may be involved in the observed mast cell-deficient genotype.  
      
5.4.1 Molecular Differences Observed Between Mast Cell-Deficient and Control Mice 
As mentioned previously, histamine is utilized by mast cells in allergic responses.  It has 
been shown previously that histamine levels were lower in Wsh/Wsh mice when compared to 
the Wsh/+ mice.5  Histidine is a precursor to histamine; therefore, it is reasonable that 
histidine levels are lower in Wsh/Wsh mice compared to Wsh/+ mice.    The levels of histamine 
measured in the aforementioned paper were below the limits of detection for the instrument 
platform; therefore, it is not surprising that histamine was not detected.  Furthermore, 
histidine and carnosine are directly involved in the same pathway as histamine.  Similarly, 
hypoxanthine is in the same line of metabolism as histidine, even though it is in the purine 
metabolism pathway, which aids in explaining observed chemical differences between the 
genotype. 
  In the microarray data, pyruvate dehydrogenase beta (Pdhb) was observed to be 
different between Wsh/Wsh and Wsh/+ mice under the allergy treatment.  Pdhb is involved in 
the citrate, or Krebs cycle, which is involved in multiple amino acid pathways, including 
leucine degradation, alanine metabolism, and tyrosine metabolism.  Pdhb is also involved in 
pyruvate metabolism, which is connected to the nicotinamide metabolism pathway, the 
biosynthesis of several amino acids including lysine biosynthesis, and is directly involved in 
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leucine biosynthesis.  The nicotinamide pathway is also listed under the affected pathway list 
determined by the gene expression analysis.  This disregulation of Pdhb expression could be 
responsible for the decrease in the amino acids and nicotinamide between the Wsh/+ and 
Wsh/Wsh mice. 
Acetylcholinesterase is statistically different between saline-treated Wsh/Wsh and 
Wsh/+ mice, as well as between allergy-treated Wsh/Wsh and Wsh/+ mice.  
Acetylcholinesterase is responsible for the conversion of acetylcholine into choline, 
explaining the choline deficit in Wsh/Wsh mice.  While there was not a statistical difference 
for acetylcholine between Wsh/Wsh and Wsh/+ mice, there is a statistical difference between 
Wsh/Wsh and +/+ mice, as well a relative decrease in acetylcholine concentrations (Wsh/Wsh <  
Wsh/+  <  +/+) as shown in Table 5.2.  Prenatal choline administration has been shown to 
affect acetylcholinesterase levels,27 although it is difficult to know the causality in this case.    
Furthermore, mast cells have also been found to express acetylcholinesterase,28 which 
supports the observed choline and acetylcholine differences being mast cell specific.   
The microarray results also show a difference for choline dehydrogenase, which 
converts choline into betaine aldehyde in the glycine, serine, and threonine metabolism 
pathway.  The down-regulation of choline dehydrogenase could be a result of the lower 
levels of choline.  Furthermore, downstream metabolites in this pathway are also shown to be 
statistically different between the genotypes.  For example, methionine is statistically lower 
in the Wsh/Wsh sample set in comparison with the Wsh/+ samples; betaine is significantly 
different between Wsh/Wsh and +/+ mice.  Furthermore, this pathway connects to the 
synthesis of multiple amino acids.   
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Given the apparent connectivity between gene expression and metabolite differences, 
a list of metabolic pathways that may be affected was generated.  Hierarchal clustering was 
then performed to determine the connectivity of this generated information.  As shown in 
Figure 5.3, the majority of statistically different metabolites have a matching differentially 
expressed pathway.  Furthermore, the pathways and metabolites are interconnected, forming 
a single network.  
 
5.4.2 The Combination of Molecular Approaches Yield Insight into Mast Cell 
Involvement in the Hippocampus 
It was previously shown that mast cell-derived serotonin contributes to neurogenesis and that 
a lack of mast cells results in spatial memory and learning deficits.6  It appears that there are 
global chemical differences present when comparing Wsh/Wsh and Wsh/+ mice, outside of the 
repertoire of chemical mediators that are localized within mast cell granules.  Furthermore, 
serotonin may not be solely responsible for neurogenesis impairment.  Pdhb is differentially 
expressed in this analysis and has been shown to increase in the rat hippocampus after 
chronic antidepressant treatments (like serotonin), in addition to other proteins that are 
associated with neurogenesis.29  Stress has also been shown to suppress hippocampal 
neurogenesis, which was found to be mediated by interleukin-1,30-31 a cytokine that mast 
cells contain2.  As previously mentioned, the Wsh/Wsh mice have been shown to exhibit 
anxiety-like, or stressed, behavior.5   
Similarly, stress has resulted in amino acid level changes in different biological 
sample matrices.  For example, amino acids have been found to change in blood plasma, 
urine, and regions of the brain as a result of stress32-37; furthermore, one of these mouse 
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models for stress also have been shown to have severe immunosuppression,38-39 which is 
interesting given that mast cells are involved in immune response.  Additional support for a 
link between mast cells and stress is that chronic stress results in increased numbers of mast 
cells in the CNS.4  Stress can also induce increased permeability of the blood-brain-barrier 
through mast cell activation,40 which could be responsible for molecular differences. 
The large number of amino acids that are affected by the presence of mast cells is 
certainly interesting.  A depletion of amino acids can result in autophagy, a catabolic process 
in which cells are degraded for energy production.41  Increased autophagy in the brain is 
observed after injury42 and complete impairment of autophagy in the brain results in 
neurodegeneration43-44.  This has not been observed; however, autophagy may be reduced 
which would result in amino acid differences in addition to hampering maintenance of the 
cellular environment and health.  Furthermore, as shown in Table 5.3, two genes for proteins 
involved in autophagy are differentially expressed.    
Choline deficiency has been linked to several behaviors or disorders.  For example, 
hippocampal neurogenesis is modulated by prenatal choline availability,45 which could be 
participating in the observed neurogenesis of the Wsh/Wsh genotype.  Likewise, investigations 
have demonstrated that choline can also affect visuospatial memory as a function of choline 
administration46-48 and affect hippocampal plasticity49, which are also affected in mast cell-
deficient mice.  This research indicates that choline may be integral to these observed 
differences.   
Acetylcholine does statistically differ between Wsh/Wsh and +/+ mice.  While 
acetylcholine has not been reported in mast cells, the presence of acetylcholinesterase has 
been shown,28 although its purpose has not been documented.  Acetylcholine is a known 
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neurotransmitter involved in a variety of functions, including learning and memory in the 
hippocampus.50  The acetylcholine deficit could be contributing to the observed defects in 
spatial memory and learning in the mast cell-deficient mice.  Furthermore, acetylcholine 
release in the hippocampus in response to anxiety and stress has been documented, which 
results in an anxiolytic effect.51-55  If acetylcholine levels are impaired, this may be 
contributing to the observed anxiety-like behavior in these mice.   
Furthermore, nicotinamide has been shown to inhibit histamine release from mast 
cells,56-58  while mast cells release histamine in response to acetylcholine.59-60  Perhaps the 
lack of mast cells results in lower expression levels of these analytes in other cell types in the 
hippocampus because they are no longer needed to regulate mast cell release.  It is possible 
that mast cell communication is necessary with other hippocampal cells to regulate the 
observed impairments in the mast cell-deficient genotype.  
Cytokines are one class of molecules that are included in mast cell granules.  
Cytokines have been related to disorders such as depression.61-62  They are also involved in 
the mediation of stress.30-31  While cytokines were not specifically investigated in this work, 
it does demonstrate another supportive link for mast cell involvement in behavior.  
Additional evidence is that mast cells have also been implicated in neuroinflammatory 
diseases, such as migraines and multiple sclerosis, which are worsened by stress.63 
 
5.5 Conclusions and Future Work 
Research has demonstrated mast cell involvement in behavior, neurogenesis, and memory.5-6   
Prior studies on this link between the immune system and the brain have focused on known 
mast cell chemical mediators, such as serotonin.  However, mast cells contribute global 
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chemical differences to the hippocampus, which may result in severe impacts on other cell 
types, such as glia and neurons.  This drastic chemical effect is observed both in brain 
metabolism and in a remarkable range of pathways through the combination of metabolomics 
and gene expression data.  Furthermore, the effect is even more surprising given that 
relatively few mast cells are present in and surrounding the hippocampus in comparison with 
other cell types.   
These global chemical differences may be implicated in the observation of behavioral 
and developmental differences observed in mice that lack mast cells.  Of particular interest is 
choline and its link to memory and neurogenesis, as well as acetylcholine and its relationship 
to stress, learning and memory, and a potential impairment of signaling in the hippocampus.  
Future work will determine if these mast cell inflicted deficiencies are contributing to these 
impairments, perhaps through supplementing Wsh/Wsh animals with these chemical species.  
Similarly, the effect of multiple amino acids differing between genotypes implies that brain 
health may be compromised, perhaps through the inefficiency of autophagy.  There are a 
variety of autophagy detection kits available to test if this is the case.  There may also be a 
cumulative developmental link, which is evidenced by significantly less neurogenesis 
observed in mast cell-deficient mice.  The combination of these high-throughput data sets 
help elucidate a variety of chemical changes, which is desirable for other biological systems 
of interest.  The global chemical differences that are observed provide a framework for future 
experiments to directly obtain specific mechanistic information for how individual analytes 
are affecting observed deficits that are inflicted by mast cells.   
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Figure 5.1 Mast cell numbers in the hippocampus.  The right hemisphere was sectioned and 
mast cells were counted in every other section in five biological replicates for each genotype.  
The black dots represent individual animals, while the grey bar is the group average + the 
standard error of the mean. 
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Table 5.1 Ions monitored in samples. Key: mass-to-charge ratio (m/z), observed (obs), 
theoretical (theor), the difference between observed and theoretical m/z values (Δ), retention 
time (RT), *MSMS confirmed, grey: RT confirmed 
 
metabolite ID Formula m/z  (obs) m/z (theor) ∆ (mDa) ∆ (ppm) RT (min)
Gly C2H5NO2 76.0397 76.0398 0.1 1.3 24.5
Beta-alanine C3H7NO2 90.0552 90.0555 0.3 3.3 17.9
Ala C3H7NO2 90.0553 90.0555 0.2 2.2 27.7
GABA* C4H9NO2 104.0710 104.0711 0.1 1.0 18.9
choline* C5H13NO 104.1076 104.1075 -0.1 -1.0 16.2
Ser* C3H7NO3 106.0507 106.0504 -0.3 -2.8 33.1
creatinine* C4H7N3O 114.0666 114.0667 0.1 0.9 17.6
Pro* C5H9NO2 116.0713 116.0711 -0.2 -1.7 40.6
Val* C5H11NO2 118.0872 118.0868 -0.4 -3.4 32.8
betaine* C5H11NO2 118.0873 118.0868 -0.5 -4.2 45.0
Thr* C4H9NO3 120.0664 120.0661 -0.3 -2.5 35.9
Cys* C3H7NO2S 122.0282 122.0276 -0.6 -4.9 43.5
niacinamide* C6H6N2O 123.0558 123.0558 0.0 0.0 18.2
creatine* C4H9N3O2 132.0779 132.0774 -0.5 -3.8 25.2
Ile* C6H13NO2 132.1028 132.1024 -0.4 -3.0 33.4
Leu* C6H13NO2 132.1028 132.1024 -0.4 -3.0 33.8
ornithine* C5H12N2O2 133.0971 133.0977 0.6 4.5 17.5
Asp* C4H7NO4 134.0450 134.0453 0.3 2.2 44.0
hypoxanthine* C3H7NO2S 137.0468 137.0463 -0.5 -3.6 40.6
acetylcholine* C7H15NO2 146.1183 146.1181 -0.2 -1.4 18.6
Gln* C5H10N2O3 147.0766 147.0770 0.4 2.7 37.2
Lys* C6H14N2O2 147.1134 147.1133 -0.1 -0.7 17.7
Glu* C5H9NO4 148.0617 148.0610 -0.7 -4.7 38.2
Met C5H11NO2S 150.0596 150.0590 -0.6 -4.0 37.1
His* C6H9N3O2 156.0775 156.0772 -0.3 -1.9 18.8
3-amino-octanoic acid C8H17NO2 160.1342 160.1337 -0.5 -3.1 21.3
methyl-lysine* C7H16N2O2 161.1283 161.1290 0.7 4.3 13.8
carnitine* C7H15NO3 162.1138 162.1130 -0.8 -4.9 21.8
Phe* C9H11NO2 166.0870 166.0868 -0.2 -1.2 39.1
Arg* C6H14N4O2 175.1187 175.1195 0.8 4.6 18.5
citrulline* C6H13N3O3 176.1027 176.1035 0.8 4.5 38.0
Tyr* C9H11NO3 182.0822 182.0817 -0.5 -2.7 39.9
acetylcarnitine* C9H17NO4 204.1238 204.1236 -0.2 -1.0 23.9
Trp C11H12N2O2 205.0968 205.0977 0.9 4.4 37.0
propanoyl-carnitine* C10H19NO4 218.1402 218.1392 -1.0 -4.6 24.9
carnosine C9H14N4O3 227.1151 227.1144 -0.7 -3.1 16.6
homocarnosine* C10H16N4O3 241.1301 241.1300 -0.1 -0.4 17.0
cytidine C9H13N3O5 244.0933 244.0933 0.0 0.0 25.8
adenosine* C10H13N5O4 268.1044 268.1046 0.2 0.7 26.8
guanosine C10H13N5O5 284.0989 284.0995 0.6 2.1 47.5
glutathione* C10H17N3O6S 308.0906 308.0916 1.0 3.2 53.5
unknow n 322.1075 50.7  
134 
 
Table 5.2 Observed metabolite levels in Wsh/Wsh, Wsh/+, +/+ mice, their corresponding p-
values, and affected associated gene pathways.  Analytes marked with an asterisk indicate 
that this is the second peak in the isotopic series due to the high concentration in addition to 
the corresponding intensity that was also monitored for the monoisotopic peak.   
 
Analyte W sh /W sh W sh /+ +/+
W sh /W sh  & 
W sh /+
W sh /W sh  & 
+/+
W sh /+ & 
+/+
Gly 2.16±0.17 2.86±0.29 2.63±0.45 0.05 0.25 0.67
Beta-alanine 1.26±0.12 1.58±0.17 1.32±0.27 0.14 0.82 0.41
Ala 14.42±0.72 17.61±1.41 18.05±2.44 0.05 0.09 0.87
GABA 38.03±0.55 39.84±1.21 36.35±1.63 0.17 0.24 0.11
choline 24.40±2.00 31.08±1.36 27.93±2.25 0.02 0.30 0.23
*GABA 5.16±0.43 6.14±0.52 4.39±0.69 0.17 0.34 0.07
*choline 1.81±0.24 2.69±0.29 2.25±0.32 0.03 0.30 0.35
Ser 10.04±0.61 11.90±0.98 13.47±1.99 0.12 0.05 0.44
creatinine 2.82±0.32 3.33±0.45 1.88±0.22 0.36 0.08 0.04
Pro 5.50±0.33 6.57±0.54 6.97±1.05 0.10 0.11 0.72
Val 7.75±0.38 8.49±0.44 9.89±1.11 0.22 0.04 0.19
betaine 1.80±0.15 1.79±0.09 2.20±0.16 0.98 0.13 0.03
Thr 6.47±0.42 7.49±0.54 8.43±1.10 0.15 0.06 0.40
Cys 4.37±0.46 5.64±0.75 5.26±1.42 0.16 0.46 0.80
nicotinamide 15.26±0.76 18.39±1.37 17.55±2.79 0.06 0.31 0.77
*nicotinamide 1.58±0.08 1.95±0.15 1.97±0.38 0.04 0.19 0.95
creatine 34.44±0.54 35.77±1.03 33.10±1.14 0.26 0.24 0.13
Ile 4.87±0.25 5.47±0.27 6.15±0.92 0.12 0.10 0.38
Leu 7.57±0.37 8.71±0.40 9.00±0.95 0.05 0.11 0.75
*creatine 15.31±0.45 16.22±0.99 13.86±0.89 0.40 0.12 0.14
ornithine 2.66±0.44 2.69±0.20 3.05±0.45 0.95 0.59 0.41
Asp 25.83±2.13 28.26±1.83 30.59±2.08 0.40 0.18 0.44
*Asp 2.18±0.23 2.65±0.35 3.59±0.73 0.27 0.03 0.21
hypoxanthine 3.53±0.36 4.72±0.43 4.15±1.00 0.05 0.48 0.55
acetylcholine 4.52±0.46 5.41±0.65 6.55±0.63 0.27 0.02 0.27
Gln 34.31±0.63 35.89±0.88 34.34±1.23 0.16 0.98 0.32
Lys 11.66±0.91 14.53±1.05 12.39±1.60 0.05 0.67 0.27
Glu 35.48±0.49 37.33±1.07 34.59±1.17 0.12 0.41 0.13
*Gln 5.84±0.43 6.91±0.50 7.67±0.82 0.12 0.05 0.42
*Lys 1.32±0.10 1.65±0.11 1.47±0.24 0.04 0.48 0.45
*Glu 9.00±0.52 9.69±0.47 10.56±0.69 0.34 0.10 0.31
Met 3.06±0.23 3.88±0.27 3.87±0.47 0.04 0.11 0.98
His 4.99±0.24 6.28±0.33 5.36±0.43 0.01 0.43 0.12
3-amino-octanoic acid 2.24±0.29 2.56±0.31 2.84±0.37 0.45 0.24 0.60
methyl-lysine 2.82±0.22 3.48±0.30 2.95±0.43 0.08 0.77 0.31
carnitine 11.19±0.71 12.32±0.50 11.92±1.54 0.22 0.62 0.77
Phe 4.26±0.27 5.04±0.29 5.57±0.69 0.07 0.05 0.42
Arg 8.90±0.86 10.45±0.78 9.07±1.13 0.21 0.91 0.33
citrulline 1.06±0.12 1.37±0.17 0.86±0.11 0.15 0.28 0.06
Tyr 3.06±0.25 3.81±0.26 4.17±0.57 0.05 0.06 0.52
acetylcarnitine 8.57±0.55 9.30±0.74 9.56±0.95 0.43 0.35 0.84
Trp 1.20±0.07 1.43±0.11 1.50±0.26 0.09 0.18 0.78
propanoyl-carnitine 1.02±0.11 1.03±0.09 1.18±0.30 0.96 0.56 0.56
carnosine 2.70±0.20 3.45±0.29 3.30±0.52 0.04 0.21 0.78
homocarnosine 3.17±0.25 3.98±0.34 3.60±0.68 0.07 0.47 0.59
cytidine 0.71±0.06 0.86±0.11 0.79±0.15 0.24 0.56 0.72
adenosine 13.11±0.76 15.06±0.89 14.95±2.54 0.11 0.39 0.96
*adenosine 2.43±0.14 2.87±0.19 3.01±0.61 0.07 0.22 0.79
guanosine 0.34±0.02 0.37±0.04 0.40±0.07 0.40 0.30 0.72
glutathione 4.01±0.30 4.18±0.25 5.29±0.57 0.67 0.05 0.06
unknown 0.06±0.02 0.07±0.02 0.04±0.02 0.76 0.48 0.38
Intensity+Standard Error p-value
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Table 5.3 Gene array analysis for Wsh/Wsh and Wsh/+ mice; differences are shown for allergy-
treated versus saline-treated and for Wsh/Wsh versus Wsh/+ mice for the saline or allergy 
treatment; Key: allergy (a), saline (s), Wsh/Wsh (SH), Wsh/+ (HET), difference (diff) 
 
SHs SHa HETs HETa
Diff 
SH 
a/s
Diff 
HET 
a/s
Diff 
SHs/
HETs
Diff 
SHa/
HETa
Involved 
in:
Gene Description
Yes No No Yes Autophagy
NFKB inhibitor interacting Ras-like 
protein 2 (Nkiras2)
Yes No No No Choline choline dehydrogenase (Chdh)
No No Yes Yes Choline acetylcholinesterase (Ache)
No No No Yes Autophagy RAS-like, family 10, member A 
(Rasl10a)
No No No Yes Amino Acids
pyruvate dehydrogenase (lipoamide) 
beta (Pdhb)
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CHAPTER 6 
 
PEPTIDE CHARACTERIZATION IN ASTROCYTES: SINGLE CELL AND CELL 
HOMOGENATE STRATEGIES 
 
Notes and Acknowledgments 
This chapter describes several efforts at characterizing astrocyte peptide content.  This was a 
collaboration with Prof. Martha Gillette’s laboratory and the described work was started by 
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Ping and I established and maintained the astrocyte cell line.  Larry Millet from the Gillette 
lab taught Ping and I how to culture cells, provided primary cultures for us to test, and 
characterized cultures for glial fibrillary acid protein content; Harry Rosenberg, another 
student from the Gillette lab, prepared and provided primary cortical cultures of astrocytes 
and prepared single cell astrocyte suspensions prior to fluorescence-activated cell sorting 
(FACS).  Jennifer Mitchell, also from Gillette’s lab, provided assistance in the preparation of 
the SCN samples.  Additionally, the majority of the LC-MS work described in this chapter 
was performed by Ping; Xiaowen Hou analyzed the FACS sample with LC-MS.  Stanislav 
Rubakhin assisted in the sample preparation for the transgenic mice.  Finally, I would also 
like to thank Prof. Mathew Whim from Penn State University for sending additional details 
regarding the acid extraction protocol.  This work was supported by the National Science 
Foundation (NSF) through CHE-0526692 and National Institutes of Health (NIH) through 
P30-081310.  
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6.1 Introduction 
Cell-to-cell signaling among neurons is fundamental to information transfer in the brain.  
However, neurons are not the most common cell type in the brain, with more glia present 
than neurons.  Glia are a heterogeneous cell type, which include, among others, astrocytes, 
oligodendrocytes, and Schwann cells. While many differences exist between neurons and 
glia, a large difference is that neurons utilize action potentials during intercellular signaling, 
while glia do not.  However, this view has recently been challenged with the finding that a 
specific subset of glia do signal in this manner.1  Because of the traditional view that 
astrocytes do not fire action potentials, this cell type was previously thought to only play a 
role in the maintenance of neuronal health and was not believed to be involved in modulating 
neuronal signaling.  However, glia do express voltage- and ligand-gated ion channels2 and G-
protein-coupled receptors,3 protein machinery that is also used in neuronal communication.  
Furthermore, studies suggest that glia also participate in chemical communication, between 
other glia and between glia and neurons.  Several roles for glia have been established, 
including the regulation of synapse formation, control of synaptic strength, and the 
production of myelin to enhance conduction of action potentials.4-5  Furthermore, glia are 
also involved or implicated in several diseases, although their roles in disorders, such as 
multiple sclerosis and glioblastoma, are not thoroughly defined.6-7   
Astrocytes, a subset of glia, are not fully characterized in terms of function and 
physiology and are believed to have the most diverse functions compared to other subsets of 
glia.    Astrocytes envelop pre- and postsynaptic terminals of neurons, which is strategic 
placement for involvement in synaptic transmission; this network is known as the tripartite 
synapse.8  Initially, glutamate was shown to induce Ca2+ changes in astrocytes,9-10 although 
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other transmitters have also produced this effect.11-12  Calcium oscillations have been 
demonstrated for astrocyte-to-astrocyte communication13-15 as well as bidirectional 
communication between neurons and astrocytes.16  Astrocytes also release “gliotransmitters,” 
many of which appear to be small-molecule transmitters.17  For example, it has been 
demonstrated that astrocytes can release glutamate through a SNARE-dependent, quantal 
mechanism, which was previously thought to be specific to neuronal synapses.18  Several 
release mechanisms have been documented, and in general, release is governed by either a 
volume regulatory response,19 which releases analyte from the cytoplasm into the 
extracellular space, or an intracellular calcium-dependent vesicle-mediated exocytotic 
release.20-21  Additionally, a large range of potential functions for astrocytes have been 
proposed.  It has been suggested that astrocytes are involved in long-term memory 
formation22 and the regulation of synaptic strength, plasticity, and transmission;4, 23-25 
however, their role in synaptic plasticity has been challenged recently.26  Furthermore, 
astrocytes exhibit heterogeneity with respect to morphology and physiology,27 which stresses 
the importance of single-cell investigations for this cell type.   
 There is also evidence that neuropeptides are expressed by astrocytes.28  For example, 
a number of studies have determined astrocytes express neuropeptide prohormone mRNA.29-
31  To become active, a neuropeptide prohormone must undergo extensive post-translational 
modifications (PTMs) via a number of enzymatic steps.  However, there is currently little 
information about peptide processing or potential PTMs.  Similarly, immunohistochemistry 
has also been used to label neuropeptide prohormones in astrocytes.32  While this technique 
enables unparalleled visualization of spatial localization, it lacks information regarding 
peptide processing.  Furthermore, antibodies are needed for the specific neuropeptide of 
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interest.  Additionally, it has been shown that regulated release of neuropeptides is possible 
by observing Ca2+-dependent release in transfected astrocytes expressing pro-atrial 
natriuretic peptide fused with emerald green fluorescent protein.33  Furthermore, the presence 
of secretory granules has recently been shown in astrocytes from human brain tissue.34   
Mass spectrometry (MS) is well-suited to detect and identify processed neuropeptides 
and determine potential post-translational modifications.  Because a prior knowledge of 
peptide content is not needed for this technique, novel peptide discovery is also possible.  
Neuropeptide discovery and processing in a variety of samples have been successfully 
identified using MS.35-38  Both electrospray ionization (ESI) and matrix-assisted laser 
desorption/ionization (MALDI) are utilized for more complete characterization given their 
complementary nature.  Furthermore, MS is also capable of detecting peptides within single 
mammalian cells.39-40  Given the heterogeneous nature of astrocytes, single-cell analysis is 
imperative.   
What peptides have been detected in astrocytes?  Neuropeptide Y (NPY), was shown 
to be colocalized with markers of the regulated secretory pathway, and a mass matching NPY 
was detected via MS, although not confirmed with tandem MS (MS/MS).41  However, it was 
not a pure astrocyte culture; >70% of the cells were glial fibrillary acid protein (GFAP) 
immunoreactive, a commonly used marker for astrocytes, although, a lack of neurons was 
confirmed.  Another work served to identify proteins in astrocytes using MS, and fragments 
from neuropeptide prohormones including ProSAAS and FMRFamide were detected and 
identified.42  However, the cell cultures were not tested for GFAP expression, leaving 
unanswered questions about the purity of the investigated astrocyte culture.  Furthermore, 
trypsin was used in the sample preparation, so it is unlikely that these would be the native 
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peptide forms.  In the current work, a careful selection of samples is chosen to ensure a pure 
astrocyte population to determine peptide content.  The progress on measuring these peptides 
is highlighted in this chapter. 
 
6.2 Experimental Procedure  
6.2.1 Sample Types 
A variety of different sample types were used to isolate peptides for identification in 
astrocytes.  The first samples that were analyzed were from an astrocyte cell line (C8-D1A, 
Astrocyte type I clone, ATCC).43  Using a cell line allows for optimization of sample 
preparation and instrumentation protocols with a homogeneous sample with unlimited 
sample quantities.  This cell line was cultured in Dulbecco’s modified Eagle media without 
phenol red until confluency under 37 °C, 5% CO2.  Trypsin was applied to the cell flasks and 
the resulting solution was diluted with media.  The cell solution was applied to culture flasks 
for passaging or to prepared coverslips for sampling; the cells were allowed to grow to 
desired confluency.  Coverslips were prepared for culturing by soaking them in dilute 
sulfuric acid overnight.  The coverslips were rinsed continuously for several minutes and 
then air dried.  Then, the coverslips were coated with poly-l-lysine (PLL) for one hour.  Both 
single cell and cell homogenates were investigated for the cell line.  Primary rat cortical 
cultures were also used for cell homogenate investigations; primary cultures are established 
directly from the brain.   
Transgenic mice (FVB/N-Tg(GFAPGFP)14Mes/J, Jackson Labs) that overexpress 
green fluorescent protein (GFP) under the control of a GFAP promoter were obtained for the 
direct isolation of astrocytes without the need for culturing.  The brain was minced and 
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digested to obtain a single cell suspension.  This suspension was sorted using fluorescence-
activated cell sorting (FACS). 
 
6.2.2 Single-Cell MALDI Sample Preparation 
The single-cell sample preparation workflow is shown in Figure 6.1.  Two stabilization 
methods were used to preserve and prepare the sample, the first of which involved incubating 
the sample in a 5% glycerol solution to stabilize the cell membrane.39-40  After removing 
excess media from the coverslips, a 5% glycerol in media solution was added and the sample 
was incubated for 15 minutes for cell stabilization.  The solution was removed from the 
coverslip by wicking it off of the surface with a Kimwipe® or by gently removing the 
solution by applying vacuum to the edges of the coverslip.  The sample is left overnight in a 
desiccator.   Matrix deposition methods used include spraying a 50 mg/mL solution of 2,5-
dihydroxybenzoic acid (DHB) matrix on the cellular surface of the glass slide via a nebulizer 
or manually depositing matrix on the surface through a capillary using gravity flow.  
Recrystallization of the matrix was performed three times with sprayed samples for improved 
ionization.  The second preparation protocol involved quickly rinsing the sample in a 
concentrated solution of DHB.44-45  This acts as a cell preservative and serves to remove salt 
from the sample, aiding in ionization.  Optionally, additional DHB can be spotted on the 
surface via gravity flow if ionization directly off of the surface is insufficient.  The coverslips 
were used as MALDI targets for direct cellular analysis.   
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6.2.3 Glia Homogenate Extraction Protocols 
Two different procedures were used for the extraction of peptides.  The first is a DHB 
extraction, based on the work of Romanova, et al.45  This involved applying a concentrated 
aqueous DHB solution to the culture flask to extract peptides from the sample.  Then, excess 
salt was removed from the sample (ZipTip, Millipore) and a combination of DHB and alpha-
cyano-4-hydroxycinnamic acid matrixes was applied to the sample to obtain a homogenous 
matrix surface for MS/MS identification.46  This procedure was applied to the astrocyte cell 
line. 
The second procedure is an acid extraction based on the work of Whim, et al.41  
Briefly, the culture medium was removed from the purified rat cortical astrocyte culture and 
the cells were rinsed with HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
buffered salt solution.  The cells were extracted with 10 mM hydrochloric acid with 0.1% 
formic acid, sonicated for 2-3 minutes, and then incubated at 70 °C for 20 minutes to 
deactivate enzymes.  Next the sample was centrifuged at 3300 rcf for 10 min and the 
supernatant was applied to a 10 kDa molecular weight cutoff filter (Microsep Centrifugal 
Devices, Pall Corporation).  The supernatant was lyophilized, resuspended in 0.1% formic 
acid, desalted (ZipTip, Millipore), and reconstituted in 0.1% formic acid.  This procedure 
was used on both the primary glia cultures and astrocytes isolated from the transgenic mice.  
This extraction protocol was also applied to the suprachiasmatic nucleus (SCN) to confirm 
that it is suitable for peptide extraction; this area has a well-known set of well-characterized 
neuropeptides.35  More specifically, the SCN is a neuroendocrine structure that contains 
approximately 10,000 highly peptidergic neurons within a small structure that is used to 
validate the implemented protocols.  
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6.2.4 Instrumentation 
A variety of instrumentation was utilized for both the single-cell and homogenate analyses 
with each offering differing performance specifications and capabilities.  Single-cell 
detection was achieved using a MALDI TOF/TOF (time-of-flight) MS instrument (Ultraflex 
II, Bruker Daltonics).  The DHB extract identifications were achieved using a MALDI Q-
TOF (quadrupole time-of-flight) MS instrument (QSTAR XL, Applied Biosystems).  
Primary cultures and transgenic mouse samples were analyzed using two additional 
instrument platforms: capillary electrophoresis (CE) coupled to an ESI-Qq-TOF-MS/MS 
instrument (maXis, Bruker Daltonics)47 and liquid chromatography (CapLC, Micromass) 
hyphenated to an ESI-IT (ion trap) MS instrument (HCTultra, Bruker Daltonics).  The LC-
MS system was also used to characterize the astrocyte cell line.   
 
6.3 Results and Discussion  
6.3.1 Single-Cell MALDI 
Initially, single-cell preparations with MALDI MS and cell homogenate preparations for LC-
MS were concurrently analyzed.  As shown in Figure 6.2, the two single-cell sample 
preparation strategies detect overlapping, but distinct peptide signals.  Complete mass lists 
from these analyses were compared against the LC-MS detected mass list.  This comparison 
is shown in Table 6.1.  The combination of matched analytes from LC-MS and distinct 
profiles from each preparation implies that both single-cell sampling strategies are needed for 
a more complete characterization.  While the LC-MS analysis identified a number of analytes 
(data not shown), none were classical neuropeptides and the analytes detected in single cells 
were not able to be identified using this technique.  However, the combined peak matches 
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from the two analytical techniques do provide confirmation that the sample preparations are 
sufficient to obtain molecular content information.     
 
6.3.2 Assaying Astrocyte Homogenates  
The DHB extraction protocol on astrocyte homogenates was done in an effort to identify 
some of the molecular species detected in the single cell preparations that were unable to be 
identified by LC-MS.  The identifications from this work are listed in Table 6.2.  While the 
identities of analytes detected in the single-cell experiments were revealed, unfortunately 
these are not classical neuropeptides.  Interestingly, most of the identifications were histone 
fragments.  Based on the article that describes this sampling protocol, there is increased 
porosity of the tissue surface.45  It is therefore feasible, that the DHB created pores in the cell 
nucleus to extract the histones.  Additionally, while the source of the cell line stated that 
these cells express GFAP, it was determined that the expression level was rare to non-
existent (data not shown). At this point, efforts were shifted to the characterization of 
astrocytes in primary cultures to gain a more representative view of this cell type. 
 The promising results from Whim’s work regarding NPY41 prompted the replication 
of this experiment, both to reproduce NPY detection and to detect other classical 
neuropeptides.  Because Whim, et al. used MALDI MS for NPY confirmation, the sample 
was initially analyzed by MALDI; NPY was not detected.  CE-ESI-MS/MS was then utilized 
for identifying the detected molecular species in the sample; the identifications are listed in 
Table 6.3.  The identification of 39 peptides from 23 proteins and enzymes was accomplished 
within a single separation.  A similarly prepared sample was also run with LC-ESI-MS/MS 
to identify additional analytes from the primary astrocyte culture.  The combined 
151 
 
identifications from LC-MS/MS and CE-MS/MS analysis are shown in Table 6.4.  There 
were 12 common identifications between the two techniques, while there were 67 total 
identifications from 25 proteins and enzymes.  However, neither of these techniques were 
able to detect or identify NPY or other neuropeptides.  To confirm that this acid extraction 
sample protocol was sufficient for neuropeptide detection, the SCN was removed and 
prepared for peptide content.  With this procedure, 12 analytes matched the identifications 
made elsewhere, including peptides from provasopressin and ProSAAS.35  This confirms that 
this procedure can be used for peptide identification and detection.   
In Tables 6.2, 6.3, and 6.4, some of the peptides identified were from a different 
animal; more specifically, they were identified from the bovine genome.  As is typical, the 
culture media contains bovine serum and this is added for routine cell culture as it aids in cell 
growth.  Cultures were also analyzed after remaining in serum-free media overnight, but 
peaks originating from serum were still detected, albeit the peak intensities were minimized.  
Furthermore, while culturing cells is advantageous in obtaining larger amounts of purified 
cell content, it is possible that these cells behave in a context dependent manner.  For 
example, the presence of neurons may be needed for expression of neuropeptides. The 
culturing process may also lead to extraneous results which could arise from a variety of 
factors such as the the age of the culture, the number of passages, how the culture was 
established, or the types of cells present.  An ideal sample would enable the collection of 
purified glia directly from the brain without cell culture.  To obtain this type of sample, 
transgenic mice were obtained that exhibit GFP/GFAP positive astrocytes. 
A suspension of single cells was prepared to be separated via FACS to obtain purified 
astrocytes directly from the mouse brain.  The pooling of two brains from these mice strains 
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enabled approximately 1 million cells to be sorted and a cell pellet was observed following 
gentle centrifugation.  This was sufficient to detect molecular species; however, the intensity 
was not sufficient for adequate fragmentation data.  One analyte was able to be detected, 
which was a fragment of ATP synthase-coupling factor 6.  Current work continues to identify 
more peptides from these samples. 
 
6.4 Conclusions and Future Work 
The identification of a large number of peptides from astrocytes was achieved, both in a cell 
line and primary cultures.  By utilizing both LC-ESI-IT-MS/MS and CE-ESI-TOF-MS/MS, a 
more complete picture of molecular content was achieved.  However, classical neuropeptides 
were not detected.  There are a variety of reasons why this may be the case.  It is possible that 
astrocytic release of peptides is constitutive rather than regulated, which would indicate that 
the peptide vesicles would be released as they are made, and so do not accumulate.  If this is 
the case, peptide concentrations within the cell could be difficult to detect.  However, 
regulated release was reported for NPY.41  Further characterization of release pathways in 
astrocytes would provide additional insight into astrocyte signaling.  Developing a sample 
preparation procedure for the isolation of peptidergic vesicles would also be beneficial; this 
would aid in minimizing the protein and enzyme content and maximizing the concentration 
of neuropeptides.  Furthermore, it is unknown if and what cues are necessary for increased 
peptide expression in astrocytes; the selected samples may lack context-specific input. 
 As mentioned previously, there is sufficient evidence that astrocytes contain 
neuropeptide prohormones, both with mRNA expression and immunochemistry data.  This 
question is still unaddressed on whether the prohormones are processed into the expected 
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peptides.  One interesting point is that most peptidomics experiments have worked with brain 
tissue samples that contain both neurons and glia and thus would contain peptides processed 
from both.  Of course, such neuropeptidomics experiments would not characterize the intact 
prohormone.   
As far as the small body of work reporting proteomics results from glia, the results 
are less conclusive.  The ProSAAS and FMRFa fragments detected the work from Li, et al. 
does not support or reject the presence of processed peptides because they used trypsin to 
digest the proteins for identification.  Furthermore, there are several known enzymatic 
pathways through which a neuropeptide can be processed.48  The subtilisin-like protease 
pathway utilizes several prohormone convertases (PC1/3, PC2, PC5) followed by 
carboxypeptidase E/H.  Transcriptomics data is now available for astrocytes, neurons, and 
oligodendrocytes.49  According to this data, PC2 and PC5 are absent in astrocytes, but are 
present in neurons.  Furthermore, astrocytes have significantly less PC1 when compared to 
neurons.  This work really makes one question whether astrocytes would process expressed 
prohormones into neuropeptides.  Additionally, two reports50-51 have shown that astrocytes 
secrete carboxypeptidase E, which may indicate this enzyme would not be available for 
peptide processing, or possibly suggest that if the prohormones are released, perhaps 
processing occurs extracellularly from the astrocyte.  This combined data suggests that the 
commonly accepted prohormone processing pathway is unlikely in astrocytes, which is 
certainly interesting given the evidence supporting neuropeptide prohormone expression and 
vesicle release.  Defining the functional purpose for carboxypeptidase E release in astrocytes 
would help to indicate if this is the case.  Furthermore, characterizing enzyme content and 
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release from astrocytes will yield information regarding potential processing pathways, 
which may facilitate novel peptide predictions.       
A wide range of diverse and interesting functions have been established for glia (and 
astrocytes).  There is still much that remains to be discovered.  Further characterization of 
this cell type will provide a more complete view of how the brain functions, and will 
certainly yield new insights into cell-to-cell communication within the brain.    
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Table 6.1 Comparison between the single-cell preparation strategies and ions detected by 
LC-MS.  An X indicates that the m/z value was detected both with LC-MS and the indicated 
single-cell preparation.    
 
m/z glycerol rinse
1304.6 x
1307.9 x
1346.6 x
1384.5 x
1518.4 x
1542.0 x x
1582.5 x
1593.2 x
1607.6 x
1763.3 x
1821.1 x
2031.9 x
2035.0 x
2348.0 x
2935.3 x
2984.4 x
3003.4 x
4936.4 x
4963.7  x x  
 
 
 
Table 6.2 Ions identified with MS/MS from the astrocyte cell line with the DHB rinse extract 
protocol.  Key: observed (obs), theoretical (theor). 
 
Precursor Sequence m/z  (obs) m/z  (theor)
Histone H4 (Osteogenic 
growth peptide) Y.ALKRQGRTLYGFGG.- 1523.8 1523.8
Histone H2A type 3 A.VLLPKKTESHHKAKGK.- 1800.9 1801.1
Histone H4 D.VVYALKRQGRTLYGFGG.- 1885.0 1885.0
Histone H4 M.DVVYALKRQGRTLYGFGG.- 2000.0 2000.1
Bovine albumin R.DTHKSEIAHRFKDLGEEHFKGLVL.I 2806.5 2806.5
Histone H2B type1-B A.VRLLLPGELAKHAVSEGTKAVTKYTSSK.- 2983.7 2983.7
Histone H2B type1-B T.AVRLLLPGELAKHAVSEGTKAVTKYTSSK.- 3054.7 3054.7
 
 
158 
 
Table 6.3 CE-ESI-MS/MS identification of peptides/proteins in an astrocyte culture from the 
rat cortex.  Key: charge (z), mass difference (Δ). 
 
m/z 
observed z
Mascot, 
∆ (mDa) Precursor Matched Sequence
822.9302 2+ -6 Ac2-067 M.GFGDLKTPAGLQVLND.Y
626.3260 3+ -12.8 Acyl-CoA-binding protein M.(Ac)SQADFDKAAEEVKRLK.T
680.3455 2+ 0 Beta actin D.ESGPSIVHRKCF.-
987.0067 2+ -2.5 Beta actin W.ISKQEYDESGPSIVHRK.C
1146.6249 1+ -1.6 Beta actin L.RVAPEEHPVL.L
694.8775 2+ -5.5 Beta actin S.ELRVAPEEHPVL.L
751.8970 2+ -9.4 Beta actin Y.NELRVAPEEHPVL.L
1119.5181 1+ 4.2 Elongation factor 1-alpha 1 D.PPMEAAGFTAQ.V
955.5333 1+ -2.6 Enolase L.YTAKGLFR.A
487.2950 2+ -3.6 Eukaryotic translation initiation factor 5A-1 E.AAVAIKAMAK.-
1072.5994 1+ -4.3 Fetuin precursor - bovine S.IPLDPVAGYK.E
1232.5793 1+ -0.3 Fibrinogen alpha chain - bovine D.PPSGDFLTEGGGV.R
975.4285 2+ -1.4 Fibrinogen beta chain - bovine -.pQFPTDYDEGQDDRPKVG.L
836.4440 2+ -25.7 Glucose-6-phosphate isomerase M.(Ac)AALTRNPEFQKLLE.W
777.8566 2+ -1.1 Glutamine synthetase 1 L.LNETGDEPFQYKN.-
930.4077 1+ 1.8 Glyceraldehyde-3-phosphate dehydrogenase L.MAYMASKE.-
965.5020 1+ 3.0 Glyceraldehyde-3-phosphate dehydrogenase G.YSNRVVDL.M
786.4319 2+ -11.4 Glyceraldehyde-3-phosphate dehydrogenase G.KVDIVAINDPFIDL.N
1046.9815 2+ -5.3 Glyceraldehyde-3-phosphate dehydrogenase L.ISWYDNEYGYSNRVVDL.M
857.9189 2+ -4.9 Heat shock 27 protein F.EARAQIGGPESEQSGAK.-
822.4454 2+ -3.6 Myosin regulatory light chain RLC-A E.FTRILKHGAKDKDD.
1143.5617 1+ -2.3 Peptidylprolyl isomerase A F.DITADGEPLGR.V
1290.6312 1+ -1.2 Peptidylprolyl isomerase A F.FDITADGEPLGR.V
761.9013 2+ -5.9 Peptidylprolyl isomerase A L.FADKVPKTAENFR.A
755.9240 2+ -6.7 Phosphoglycerate kinase 1 L.LEGKVLPGVDALSNV.-
981.0332 2+ -11 Prolifin-1 F.VSITPAEVGVLVGKDRSSF.F
487.2922 2+ -1.8 Protein S100-A11 F.LQTSQKRI.-
614.8816 2+ -6.4 Protein transport protein Sec31A L.KVVLSQASKLGV.-
833.9548 2+ -9.9 Ptbp1 protein L.LVSNLNPERVTPQSL.F
1012.5445 1+ -16.3 Pyruvate kinase isozyme M1 T.NTMRVVPVP.-
792.3981 2+ -3.5 Serum albumin precursor - bovine R.DTHKSEIAHRFKD.L
877.4514 2+ -2.4 Serum albumin precursor - bovine R.DTHKSEIAHRFKDLG.E
783.8550 2+ 3.6 Thymosin beta-4 precursor M.(Ac)SDKPDMAEIEKFD.K
717.7021 3+ -8.4 Thymosin beta-4 precursor -.(Ac)SDKPDMAEIEKFDKSKLK.K
693.3671 2+ -0.1 Vimentin L.RETNLESLPLVD.T
1091.4948 2+ -7.1 Vimentin K.TVETRDGQVINETSQHHDD.L
1212.0552 2+ -3.8 Vimentin K.TVETRDGQVINETSQHHDDLE.-
861.3898 2+ -0.2 Vimentin D.GQVINETSQHHDDLE.-
689.8805 2+ -15.1 Voltage-dependent anion channel-like protein N.AGGHKLGLALELEA.-  
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Table 6.4 Combined identifications from CE-MS/MS and LC-MS/MS. 
 
Precusor
# of 
fragments 
identified
Ac2-067 1
Acyl-CoA-binding protein 1
Beta actin 5
Elongation factor 1-alpha 1 1
Enolase 1
Eukaryotic translation initiation factor 5A-1 1
Fetuin precursor - bovine 1
Fibrinogen beta chain - bovine 2
Glucose-6-phosphate isomerase 1
Glutamine synthetase 1 1
Glyceraldehyde-3-phosphate dehydrogenase 4
Heat shock 27 protein 2
Myosin regulatory light chain RLC-A 1
Peptidylprolyl isomerase A 5
Phosphoglycerate kinase 1 1
Profilin-1 1
Protein S100-A11 1
pyruvate kinase isozyme M1 1
Pyrimidine-binding protein 1
Sec31l1 protein (Fragment) 1
Serum albumin precursor  - bovine 2
Thymosin beta-4 3
Vimentin 4
Voltage-dependent anion channel-like protein 1
Voltage-dependent anion-selective channel protein 1 1
Total 44
# of proteins/enzymes ID'd 25  
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CHAPTER 7 
 
METABOLIC DIFFERENCES OF SPECIALIZED SAMPLES: NEURONAL 
CULTURES, CELL CLUSTERS, AND SINGLE CELLS FROM APLYSIA 
CALIFORNICA  
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7.1 Introduction 
Microscale analyses of single cells or cell clusters can provide useful information that is 
often lost with tissue homogenates.  Especially in the central nervous system (CNS), diverse 
cell types are present, and even cells of the same types exhibit chemical heterogeneity.1-3  By 
moving to single-cell samples, complexity is also minimized.  There are several analytical 
technologies that are capable of making measurements of cellular content on a single-cell 
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level.4-6  Mass spectrometry (MS) is particularly useful due to its low limits of detection, 
wide dynamic concentration range, and its ability to detect and identify analytes via 
fragmentation.  Like the metabolomics investigations in Chapters 4 and 5, capillary 
electrophoresis (CE) coupled to electrospray ionization mass spectrometry (ESI MS) is used 
for the following metabolic analyses.  This work is expands upon prior work listed in Chapter 
4; here, preliminary data is presented for isolated single Aplysia californica neurons and 
neuronal clusters.  The cells investigated represent three separate applications of 
metabolomics to highlight changes induced by cell culture, to alleviate difficulties in the 
selection of neurons, and to examine the molecular content of a seemingly homogeneous cell 
cluster. 
The first investigation involves cell culture.  Cell culture is often implemented with 
Aplysia neurons in order to perform experiments under a predefined set of conditions to gain 
functional or biological information in a less complicated environment.  Furthermore, 
culturing can yield valuable information that is difficult to obtain in vivo, such as axon and 
synapse formation and strength.7-10  Culturing also enables the intrinsic properties of the 
neuron to be monitored without synaptic input or the function of a small neuronal circuit to 
be determined, which would be difficult to obtain in the intact system.11  How do cultured 
versus freshly isolated neurons differ?  This is important to know if one is to make biological 
or functional conclusions from experiments with cultured cells, which are then extended to 
what occurs in vivo.  For this work, two similar neurons are compared against their cultured 
counterparts, the B1 and B2 neurons from the buccal ganglion.  These neurons have been 
shown to be similar both in neuropeptide12 and metabolite content (Chapter 4) and are 
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involved in gut motility.13  They have also been included in cell culture experiments 
regarding neurite outgrowth and synapse formation.8, 14 
 The second investigation includes metabolically characterizing the R3-13 ganglion.  
The R3-13 cluster is involved in cardiac function,15 which is induced by a neuropeptide16.  
This neuronal cluster is easily identifiable and is well characterized in terms of physiology 
and function as a whole.  However, the individual neurons within this cluster are difficult to 
identify and isolate without damaging the other neurons in the cluster.  Many of the 
investigations regarding this ganglion characterize it as a whole, in part due to the difficulty 
in isolation and because the individual neurons within the cluster were thought to be 
homogeneous.  However, the neurons of this ganglion innervate different areas, such as the 
heart and kidneys, which indicates that each neuron may be responsible for different 
actions.17  Furthermore, little information is available regarding the metabolites that are 
present, with the exception of glycine, which has also been suggested to be a 
neurotransmitter.18-19  Because of the difficulty in identifying the individual neurons within 
the cluster, the entire cell cluster was extracted; therefore, cell-to-cell differences were not 
investigated.  To quickly determine molecular content, the same ion list used to characterize 
Aplysia neurons in Chapter 4 was used to observe eluting analytes.  In an effort to determine 
if unique molecular entities were present, the cluster was compared against the other cell 
types that were described in Chapter 4 because these isolated neurons are very different from 
the cluster with respect to appearance and functionality.  Unique signals to the cluster have 
the potential to be localized to individual neurons, which could yield information regarding 
their function. 
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The last example of a single neuron study represents initial efforts to characterize the 
L7 motor neuron, which is involved in the gill-withdrawal reflex.20-22  This reflex has been 
thoroughly investigated by Kandel and colleagues because of its unique role in specific types 
of learning and memory.23  However, the chemical signal responsible for this response is not 
well characterized.24  Transcriptome data has been collected to characterize the CNS and 
specific neurons from Aplysia, including the L7 neuron.24  Three proteins that were L7-
specific were determined to be candidate signaling molecules, while 362 transcripts were 
found to be enriched specifically in L7 neurons.  To complement the transcriptomics data, the 
small molecule content of this cell type is examined here.  However, as is typical for neurons, 
the identification of this neuron involves functional tests and cannot be solely identified 
based on location.  The number of candidate neurons is able to be limited to two; here, these 
two neurons are isolated, one of which is the L7 motor neuron, and the chemical differences 
between these two neurons are highlighted as well as their molecular content.  Multiple 
animals are used to distinguish chemical differences between these neurons.  Once these two 
neurons are well characterized, the hope is that future L7 experiments can use the specific 
small molecular signature for identification. 
 Metabolite profiling enables three different approaches to better understand Aplysia 
neurons.  First, it is determined that the extent of metabolic change induced by cell culture is 
dependent on the neuron type.  Second, initial chemical characterization of the R3-13 cluster 
results in the observation of unidentified analytes that appear to be specific to the cluster.  
Finally, preliminary investigations into probing the chemical content of the L7 neuron allow 
it to be determined chemically, which is a necessary precursor to future experiments of this 
cell type.   
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7.2 Experimental Procedure 
7.2.1 Sample Preparation 
The sample preparation strategy is similar to that stated in Chapter 4, so only differences are 
highlighted here.  Three different experiments with isolated neurons are described: 
comparison of freshly isolated and cultured B1 and B2 neurons, putative L7 neuron analysis, 
and investigation of the R3-13 cluster.  Cell culturing experiments were performed as shown 
previously.25   Briefly, individual B1 and B2 neurons were isolated and placed in pre-
manufactured cell culture plastic Petri dishes.  The cell culture was allowed to develop for 24 
h in artificial seawater (ASW) supplemented with antibiotics (100 units/mL penicillin G, 100 
μg/mL streptomycin, and 100 μg/mL gentamicin) at room temperature.  The cultured neurons 
were immersed in the ASW/glycerol (v/v 66.7%/33.3%) solution prior to isolation.  In a 
different experiment, two neurons were isolated from the same animal, one of which is the 
L7 neuron, with neuron pairs being isolated from four total animals.  These neurons were 
chosen by their location and size; however, the absence of electrophysiological identification 
and presence of several similar neurons in the same area of the abdominal ganglion resulted 
in uncertainty in L7 identification.  Three R3-13 clusters were also isolated for metabolite 
characterization.  Isolated neurons were placed and preserved in an extraction solution (50% 
(v/v) methanol with 0.5% (v/v) acetic acid) prior to CE-ESI-MS analysis. 
 
7.2.2 CE-ESI-MS 
Detailed explanations of the instrument platform have been previously described in Chapters 
3 and 4.  Briefly, the CE separation is achieved with 1% formic acid as the background 
electrolyte and by applying 20 kV at the inlet, while the outlet is at ground.  Hydrodynamic 
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injections of 6 nL were achieved via a 15 cm height difference with respect to the CE 
capillary outlet.  A MicroTee (Idex Health & Science LLC, Oak Harbor, WA) is utilized for 
the CE-ESI sheath flow interface, equipped with a grounded stainless steel emitter (130 µm 
ID, 260 µm OD, part 21031A, Hamilton Company, Reno, NV, USA).  The sheath flow (50% 
(v/v) methanol with 0.1% (v/v) formic acid) is supplied through the emitter at 750 nL/min.  
The ions were monitored with a micrOTOF ESI-time-of-flight (TOF) mass spectrometer 
(Bruker Daltonics, Billerica, MA). 
 
7.2.3 Data Analysis 
For the R3-13 cluster and culturing comparison experiments, data processing was performed 
as mentioned in Chapter 4.  Briefly, initial data mining was completed by determining eluting 
ions in m/z-selected ion electropherograms from m/z 50 to 500 with a step size of 0.5 Da.  
After determining the eluting species from these isolated, identified neurons, the total analyte 
list was minimized to 140 analytes that would be monitored.  Similarly, for the L7 
experiment, a total of 241 combined analytes from the two putative L7 neurons from 4 
animals (8 total neurons) were detected and monitored.  This analyte list was minimized to 
169 compounds after the removal of peaks due to contamination, HEPES-related ions, ion 
fragments, adducts, and ions that were specific to only one animal.  Unsupervised principal 
component analysis (PCA) was used for all of the described experiments using Markerview 
1.1 software (Applied Biosystems, Carlsbad, CA, USA).  It was determined that the 
molecular profile of the neurons from one of the animals differed significantly from the other 
three animals and was excluded from the analysis. 
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7.3 Results and Discussion 
Three separate investigations were performed to gain insight into different aspects of Aplysia 
neurons.  The first set of experiments served to determine how two different neurons respond 
to cell culture conditions, where the variability between freshly isolated and cultured neurons 
was determined via PCA.  The second investigation involved initial efforts to characterize the 
metabolic content of the R3-13 cell cluster to determine any uniquely identifiable markers in 
comparison with other cell types from Aplysia.  Finally, two candidates for the L7 motor 
neuron are characterized for metabolite content and can be separated by PCA, indicating that 
the L7 neuron can be identified chemically.  
 
7.3.1 Cultured Neurons 
In investigations where culturing is utilized, one should assume that differences may be 
present with respect to the cell in its intact system.  PCA was implemented to determine the 
extent of the chemical differences between cultured and isolated neurons; the PCA results are 
shown in Figure 7.1.  For the B1 neuron, the majority of the variance is observed along the 
PC1 score axis (70.4%), which is also the axis along which clustering is occurring.  
Conversely, the B2 neurons separate along the PC2 score axis, where only an 8.2% variance 
is observed between cultured and isolated cells.  These results suggest that the variability 
between cultured and non-cultured cells is dependent upon cell type.  Furthermore, it is 
interesting that these two neurons respond differently to culturing given that they are 
metabolically similar compared to other isolated neurons from Aplysia, as shown in Chapter 
4 (Figure 4.5); they are also similar with regard to peptide expression and distribution.12, 26  
B1 and B2 neurons have also been shown to be similar in culture, exhibiting analogous 
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axonal formation.8  B1 neurons did show relatively higher metabolite variability (Chapter 4); 
perhaps this metabolic variability results in differences in response to culturing.   
While these two different neurons appear to respond differently in culture from a 
metabolomics standpoint, the cultured versus freshly isolated neurons do both cluster 
separately from one another.  This is not surprising given that culturing does expose the cell 
to an environment that is drastically different than what is encountered in vivo.  A direct 
chemical comparison between cultured and freshly isolated neurons was unable to be found 
in the literature, likely because many investigations utilizing cell culture with Aplysia focus 
on synapse formation and electrophysiological responses.  However, there have been reports 
of neuron-neuron connections that can be established in culture that do not occur in vivo.27-28   
When observing specific metabolite differences between cultured and freshly isolated 
neurons, cultured neurons appeared to have relatively lower intensities of amino acids.  This 
is not too surprising given that the neurons are cultured in artificial sea water, but it is 
surprising that these two different neurons, which are similar in many respects, respond 
differently to this treatment.  Perhaps, media with essential amino acids, similar to what is 
used in mammalian cell culture, would prevent the cell from being metabolically depleted.  
What other chemical changes may be present?  Because these cells were monitored only for 
small molecule content, it is unknown how culturing affects neuropeptide or gene expression.  
While analytes may be present in large enough quantities to elicit a cellular response in a 
neuronal network, the response may be more pronounced in vivo.  Since these cells are 
peptidergic, a similar experiment could be performed on neurons with a known small 
molecule neurotransmitter to determine if there is a concentration difference.  These results 
demonstrate that caution must be taken when performing experiments in culture and to 
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consider what differences, chemical or otherwise, may be present between isolated and 
cultured neurons.     
 
7.3.2 Investigation of R3-13 Cluster  
As mentioned previously, the R3-13 ganglion has not been fully characterized with respect to 
metabolite content.  Previous investigations regarding this ganglion have traditionally been 
done on the entire ganglion rather than its individual cellular components.  As a first 
approach, the cluster was initially characterized using the predefined analyte list from 
Chapter 4 and was used as a comparison with the single neurons analyzed in Chapter 4 
utilizing PCA.  The ganglion does cluster separately from the other cells (data not shown), so 
the individual ion profiles were compared between the cluster and the other isolated neurons 
to determine how they are metabolically distinct.  For the most part, many of the ions from 
the cluster were similar to those detected in the single neurons from Chapter 4.  However, a 
few analytes appeared to be somewhat specific to the ganglion.  In Figure 7.2, three ions are 
displayed that appear to be either highly expressed in the cluster in comparison with the other 
neurons.  The top panel of Figure 7.2 is a representation of glycine content for the 
investigated neurons.  The R3-13 neurons appear to have relatively high glycine content, as 
do the R2 and LPl1 neurons.  Previous work has demonstrated that the R3-13 ganglion does 
contain increased levels of glycine and has been suggested to serve as a potential 
neurotransmitter in this cluster.18-19  The other two ions that appear to distinguish the 
ganglion from other neurons are unidentified.  The m/z 242 ion (middle panel, Figure 7.2) is 
doubly charged and could be an unidentified neuropeptide (M+H 484.25); however, this 
mass does not match any of the previously determined peptides from this cluster.15  A 
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metabolite search to determine the possible identity of the m/z 265 yields two potential 
matches: alpha-N-phenylacetyl-L-glutamine and N-γ-acetyl-N-2-formyl-5-
methoxykynurenamine.  These metabolites are involved in phenylalanine and tryptophan 
metabolism, respectively.  Future work will characterize the identity of these ions and to 
determine if they have any biological significance.  Single cell metabolomics investigations 
could also be done to the individual neurons within this cluster to determine if they are really 
homogeneous cells that happen to innervate different areas or if they are heterogeneous in 
their chemical composition. 
 
7.3.3 L7 Analysis 
A combined total of 241 analytes were detected in the two L7 candidate neurons.  This list of 
analytes was minimized to 169 analytes after removing contamination peaks, adducts, 
HEPES-related ions, ion fragments, or ions that were specific to the neurons of one animal; 
these ions were monitored in the two L7 candidate neurons.  Rather than identifying all of the 
combined 169 analytes that were detected in the two isolated neurons, PCA was first applied 
to the sample set to determine if the two neurons could be chemically differentiated.  In the 
isolation of L7 neurons, limiting the possibilities to two neurons is achievable, but it is 
difficult to unambiguously identify the true L7 neuron out of these two candidates without 
lengthy electrophysiology experiments.  Therefore, the potential for distinguishing these two 
neurons from each other using their metabolic profiles was investigated.  It appears that the 
two can be chemically distinguished, as shown in Figure 7.3, where the neurons from three 
animals were included (6 total neurons, 2 technical replicates).  Also, during the isolation, the 
first neuron to be isolated, labeled L7-1, was visually determined based on location to be the 
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most likely candidate out of the two to be the L7 neuron.  Therefore, it is promising that the 
L7-1 labeled neurons cluster separately from the L7-2 labeled neurons.  This also implies that 
the identity of the L7 neuron can be distinguished based on its metabolite profile. 
Next, individual ions were investigated to determine the cause of this observed 
clustering; several of these m/z values are listed in Figure 7.4.  Two of these ions are 
acetylcarnitine and propanoyl-carnitine; however, the functional reasoning for this difference 
in abundance is unknown.  The m/z 203 ion matches to the calculated mass of several 
dipeptides, while searching metabolite databases for the potential identity of the m/z 255 ion 
yielded no results.  Fragmentation of these ions may provide additional insight into the 
identities of these ions.  While it is unknown if these molecules serve some functional 
purpose for the L7 neuron, these analytes can be used as a chemical marker to identify these 
neurons.     
The transcriptome and in situ hybridization data collected for the L7 motor neuron 
suggested that this neuron may use peptides from the Mytilus inhibitory peptide (MIP) 
prohormone for cell-to-cell signaling.24  Previous work has shown how this prohormone is 
processed,29 so the data was searched for matches to these known peptides.   As shown in 
Table 7.1, two detected masses correspond with MIP-related peptides.  Upon further 
inspection, two additional masses were found that match FMRF-amide-related peptides.    
These two eluting ions also have similar retention times (15.6 and 15.7 min), which is not 
surprising because their respective sequences differ by only one amino acid.  These detected 
ions do not appear to be specific to either L7-1 or L7-2 neurons; however, this preliminary 
data is promising that neuropeptides may be present in these samples.  Future work will 
involve identifying these signals with MS/MS, analyzing standards for additional 
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confirmation using retention time, or using complementary ionization techniques to confirm 
their presence. 
 
7.4 Conclusions and Future Work   
This work expanded upon the characterization of Aplysia neurons in Chapter 4 with three 
different applications.  The data from the culturing experiments suggest that the extent of 
neuronal response under these conditions is cell type dependent, even if the cells are similar 
biochemically.  Other Aplysia neurons that are commonly cultured can be investigated to 
establish the degree of biochemical differences that may be present.  Complementary 
chemical analyses, including peptide and protein characterization, would yield a more 
complete view of chemical response as a result of cell culture.   
Several ions appear to be metabolically unique to R3-13 ganglion; future 
investigations will serve to identify these ions with MS/MS.  Additional work can be done to 
determine if these analytes are localized to any of the individual neurons of this cluster 
and/or if they serve any functional purpose.  Likewise, it appears that the L7 neuron can be 
chemically identified from the other candidate neuron.  Electrophysiological confirmation of 
the L7 neuron followed by metabolite extraction can confirm which neuron corresponds to 
which molecular profile.  This analytical approach can also detect metabolites and peptides 
from the same sample.  Future work will implement MS/MS for confirmation of the presence 
of putative neuropeptides in these neurons; if they are indeed neuropeptides, follow-up 
experiments will determine if they are involved in the gill-withdrawal reflex.   
In all of these experiments, data was obtained that reveals molecular differences that 
are unique to a cell type, cluster, or cellular environment.  The characterizations of these 
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different biological models provide a strong foundation for future experiments regarding 
these cell types and the influences that cellular environments can induce on the single-cell 
level. 
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Figure 7.3 PCA for putative, isolated L7 neurons. Top: PCA plot of L7-1 (blue) and L7-2 
(red) neurons.  The first letter of the sample name refers to the animal and the last digit refers 
to a technical replicate (1 or 2).  Bottom: Scores Plot with ions detected from the two 
neurons. 
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Table 7.1 Putative matches for peptides present in the L7 motor neuron. Key: ࢤ (theoretical-
observed mass). 
 
Precursor Peptide 
Sequence
theoretical 
mass
observed 
mass  ࢤ (mDa)
MIP-related peptides GAPRFVa 644.375 644.375 0
MIP-related peptides GSPHFIa 655.344 655.330 14
FMRFa-related peptides FMRFa 598.304 598.304 0
FMRFa-related peptides FLRFa 580.348 580.357 -9  
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